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1
CHAPTER 1: MITOCHONDRIAL QUALITY CONTROL AND DISEASE: INSIGHTS
INTO ISCHEMIA-REPERFUSION INJURY
(This Chapter contains previously published material. See Appendix B)
1. Introduction: Mitophagic Balance in Acute and Chronic Disease
Cardiovascular and neurologic diseases are leading causes of morbidity and
mortality in the U.S.[1]. Cardiovascular disease can result in acute injuries sustained by
both the heart and the brain in the form of acute myocardial infarction (AMI) and stroke.
AMI and stroke are induced by a cessation of blood flow (ischemia), caused by blockage
of one or more of the coronary or cerebral arteries that supply the heart or brain. This
cessation of blood flow will subsequently lead to tissue hypoxia or anoxia and, ultimately,
necrotic cell death (characterized by cellular swelling and membrane rupture due to
energy failure). It is well-known that although restoration of blood flow (reperfusion) is
essential to salvage ischemic tissue, this can also, paradoxically, exacerbate damage
from several cellular alterations including excessive reactive oxygen species (ROS)
production from mitochondria [2-4]. ROS production will lead to mitochondrial damage
and, ultimately, mitochondrial failure and programmed cell death (regulated by
mitochondrial permeability transition or outer membrane permeabilization) [5, 6].
Ultimately, cell death observed during ischemia and reperfusion in both heart and brain
occurs over a broad spectrum of cell death phenotypes depending on the duration and
severity of the ischemic insult. This process occurring at the level of the tissue has been
termed lethal ischemia/reperfusion (I/R) injury.
In addition to acute injuries such as stroke or AMI, the incidence of chronic
neuropathologies (including, for example, Parkinson’s Disease (PD) and Alzheimer’s
Disease (AD)) are on the rise as the average lifespan continues to increase [7, 8]. PD
and AD are neurodegenerative diseases that affect different parts of the brain and are
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typically seen in the elderly, although inherited mutations may also lead to disease in
younger patients. PD is a movement disorder and, while many forms of hereditary and
acquired PD have unique mechanistic causes, all result in a pathologic dysfunction and
death of dopaminergic neurons. AD is a neurodegenerative disorder that affects the
elderly and causes memory loss and declined cognitive function. The pathological factors
of the disease consist of the presence of amyloid-β plaques and neurofibrillary tangles in
the brain [9]. Although I/R injury, Parkinson’s Disease, and Alzheimer’s Disease differ in
terms of their etiology, the literature suggests that loss of mitochondrial integrity play a
central role in each of these disease processes.
It is well-established that mitochondria are key regulators of cell fate, controlling
survival (via the production of ATP that fuels cellular processes) and, conversely, death
(via the induction of apoptosis).

Indeed, mitochondrial dysfunction has been well-

characterized as a precursor to cell death [10-13]. Therefore, it is essential to have
stringent control mechanisms regulating the quality of mitochondria to avoid the
pathologic effects of dysfunctional mitochondria on the cell.
While the negative roles of mitochondrial failure and apoptosis are welldocumented, much less is known of the causal role of mitochondrial quality control in
disease and the potentially nuanced role for these mechanisms in different disease
settings. Importantly, evidence suggests a divergent role of mitochondrial quality control
in acute vs. chronic disease.

Defects in the mechanisms that regulate quality of

mitochondria are recognized to play a large role in chronic diseases such as PD and AD,
but, to date, their role in the acute setting of I/R injury is poorly understood. In contrast,
evidence supports a salutary role for mitochondrial quality control in acute cardiac and
neurologic injury, suggesting quality control mechanisms can serve both survival and
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death functions depending on the nature of the disease. This Chapter aims to: (i) discuss
the molecular mechanisms involved in mitochondrial quality control including
mitochondrial dynamics and mitophagy (Fig. 1-1), (ii) detail the role that mitochondrial
quality control plays in chronic and acute neurodegenerative and cardiovascular
diseases, and (iii) provide a better understanding of the intricacies and balance of this
process in the progression of acute vs chronic diseases.
2. The Axes of Mitochondrial Quality Control
2.1 Mitochondrial Dynamics: To Divide or Not to Divide?

Fig. 1-1. The mitochondrial quality control cycle. The mitochondrial quality control cycle involves a
dynamic process of fission, fusion, mitophagy, and biogenesis. When mitochondria become depolarized or
dysfunctional, they are marked for degradation. Once marked, the unhealthy component of the mitochondria
will undergo fission from the healthy mitochondrial network. Certain damaged mitochondria can fuse with
other healthy mitochondria in an attempt to salvage that mitochondrion, but typically dysfunctional
mitochondria will undergo mitophagy. When the dysfunctional mitochondria are segregated from the healthy
mitochondrial network, mitochondria will accumulate mitophagy markers that will recruit the phagophore or
endosome. The phagophore or endosome will fuse with the lysosome to degrade the mitochondria. Once
degraded, the cell will recycle the amino acids and fatty acids to enable the remaining healthy mitochondrial
network to grow and divide through biogenesis.
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Within the cell, mitochondria exist in an ever-changing dynamic state, where
mitochondrial networks are constantly elongating and dividing (i.e., mitochondrial fusion
and fission, respectively). The balance of these two events provides an equilibrium of
small fragmented mitochondria and long interconnected mitochondrial networks, and is
thought to be essential for mitochondrial homeostasis, cell stability and cell survival (1)
[14, 15]. Fission plays a role in segregating dysfunctional mitochondria that contain
damaged proteins, destabilized membranes, and mutated or damaged mitochondrial
DNA (mtDNA) [16-20]. Fusion, in contrast, has been shown to aid in equilibration of matrix
metabolites, intact mtDNA, and even membrane components such as Complex I of the
electron transport chain [16, 21-24]. Fission and fusion are both regulated by a family of
dynamin-related proteins (DRPs). These proteins are unique in that they are large selfassembling GTPases that also possess the capability of assembly stimulated GTP
hydrolysis [25]. Through the work of DRPs, the mitochondrial network can be in constant
communication to ensure a healthy connected network, while at the same time allowing
the distribution of mitochondria to specific sites of the cell via transport on actin or
microtubule networks [26, 27].
2.1.1 Mitochondrial Fission
The primary mediator of fission is dynamin related protein 1 (Drp1), which has
been shown to be essential for noncytokinetic mitochondrial division [16, 28]. Drp1 is
distributed diffusely throughout the cytosol and, when activated through post-translational
modifications (predominantly phosphorylation/dephosphorylation), translocates to the
outer mitochondrial membrane via actin and microtubule mechanisms [29-33]. These
post-translational

modifications,

described

in

detail

below,

include

phosphorylation/dephosphorylation, ubiquitination, and sumoylation, in a cell-specific
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manner [34, 35]. Once positioned on the outer mitochondrial membrane, Drp1 interacts
with four mitochondrial-bound proteins that serve as Drp1 receptors (mitochondrial
dynamic proteins of 49 and 51 kDa (Mid49 and Mid51), mitochondrial fission protein 1
(Fis1), and mitochondrial fission factor (Mff), where it constricts and cleaves the
mitochondria (Fig. 1-2A) [36-38]. Fis1 is an 18-kDa adaptor protein anchored to the outer
mitochondrial membrane and has been implicated in recruiting Drp1, as well as
modulating the assembly of the fission
complex [39, 40] Fis1 is thought to be
required

for

mitochondrial

fission,

although this remains controversial as
other groups have found it to be
dispensable in the fission process [38, 41,
42].
Fission is regulated by numerous
post-translational modifications of Drp1
Fig. 1-2. Mitochondrial dynamics. A) Fission is

as well as endoplasmic reticulum (ER)- mediated by a family of dynamin related proteins
mitochondrial

(Drp). Activated Drp1 translocates to the mitochondrial

contact

sites. membrane where it interacts with Drp1 receptors (Mid

Phosphorylation/dephosphorylation

one the main regulators of Drp1 and is
carried out at two different serine sites
located 20 amino acids apart (Ser616 and
Ser637) [43]. Phosphorylation of Ser616
is associated with Drp1 activation and is
phosphorylated

by

cyclin

49, Mid51, Mff) and Fis1 to create the fission complex.

is Drp1 oligomers constrict and divide the mitochondria.

dependent

B) Fusion is mediated through the mitofusins (Mfn1/2)
and optic atrophy 1 (Opa1). The mitofusins mediate
the fusion of the outer mitochondrial membrane, while
Opa1 mediates fusion of the inner mitochondrial
membrane. Mitofusins are anchored to the outer
mitochondrial membrane and interact with each other
and form a hemifusion stalk. The stalk then grows into
a lipidic hole and finally reestablishes membrane
continuity. Opa1 forms a fusion pore for the inner
mitochondrial membrane via its cardiolipin binding
domain.

6
kinase 1 (CDK1), extracellular signal-regulated kinase (ERK1/2), and protein kinase C
delta (PKCδ) [44-46]. CDK1 induces mitochondrial fragmentation during mitosis [44].
ERK1/2 and PKC induces Drp1-mediated mitochondrial fission via increases in ROS
production during hyperglycemic conditions and hypertensive neuroencephalopathy
respectively [45, 46]. Ser637 is phosphorylated by protein kinase A (PKA),
calcium/calmodulin-dependent protein kinase 1 alpha (CAMKIα), and the Rho-associated
coil-containing protein kinase 1 (ROCK1) [34, 35, 47]. PKA-phosphorylated Drp1 has
been shown to have decreased GTPase activity and result in decreased fission during
starvation, stress, or exercise. Studies in neurons and cardiac tissue exposed to oxygenglucose deprivation (OGD) and ischemia-reperfusion respectively demonstrate
calcineurin-mediated dephosphorylation of Ser637, subsequently leading to Drp1
activation, mitochondrial fission, and apoptosis [33, 48, 49]. Conversely, CAMKIα –
phosphorylation of Ser637 results in enhanced fission during conditions of high
extracellular K+ (inducing Ca2+ influx) in primary rat hippocampal neurons [33, 35, 47].
Additionally, ROCK1-phosphorylation of Ser637 has been demonstrated to induce
mitochondrial fission in podocytes and endothelial cells of mice with metabolic syndrome
and diabetes [34]. Phosphorylation of the same residue leading to opposite effects points
to the complexity of Drp1 regulation that is likely dependent on cell type, extracellular
conditions, as well as intracellular status.
Recent literature also suggests a role for the ER in mitochondrial fission. Studies
conducted in both yeast and mammalian cells have shown that ER tubules will wrap
around the mitochondria and mediate constriction before Drp1 recruitment via the ERlocalized inverted formin 2 (INF2) mechanisms [50, 51]. INF2 is thought to drive initial
mitochondrial constriction that provides sites for subsequent Drp1 recruitment and
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secondary constriction [51]. The multiple mechanisms involved in the regulation of fission
underscore the complexity of this process and may provide insight into potential
mechanisms by which dysregulated mitochondrial dynamics may interact with disease
processes.
2.1.2 Mitochondrial Fusion
Fusion is mediated by three different GTPases: Optic Atrophy 1 (Opa1), Mitofusin
1 (Mfn1) and Mitofusin 2 (Mfn2) [24]. Both Mfn1 and Mfn2 mediate fusion of the outer
mitochondrial membranes, while Opa1 mediates the fusion of the inner mitochondrial
membrane, along with its role in maintaining normal inner membrane cristae structure
[52-54]. Mitofusins, which are required for fusion, are anchored to the outer mitochondrial
membrane where they interact and form a hemifusion stalk to initiate the joining of two
mitochondrial membranes [16, 55]. The stalk then grows and creates a lipidic hole as well
as a hemifusion diaphragm to reestablish membrane continuity. Finally, a fusion pore is
made for inner membrane fusion via the lipid binding domain in Opa1 that is specific for
cardiolipin [55, 56] (Fig. 1-2B).
Fusion of the inner and outer mitochondrial membrane is mediated mainly through
proteolytic cleavage and ubiquitination respectively. Opa1, in mammals, consists of eight
different isoforms generated by alternative splicing of three of the 30 Opa1 exons [57,
58]. Membrane-bound long (L)-Opa1 can be further processed via two proteolytic
cleavage sites (S1 and S2), generating short (S)-Opa1 forms [54]. Proteolytic processing
is carried out predominantly through two intermembrane space AAA-proteases (ATPases
associated with diverse cellular activities): (i) overlapping with m-AAA (OMA1) cleaving
at the S1 site and (ii) yeast mitochondrial DNA escape 1-like (YME1L) cleaving at the S2
site [59, 60]. Every (L)-Opa1isoform contains a S1 cleavage site, while about half of the
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(L)-Opa1 isoforms contain both S1 and S2 cleavage sites [61, 62]. Under normal
physiological conditions S1 and S2 are constitutively cleaved to produce a 50/50 ratio of
(L)-Opa1 and (S)-Opa1. The balance in Opa1 isoforms is thought to mediate the balance
between mitochondrial fission and fusion [63]. Under pathophysiologic conditions, such
as membrane depolarization, low levels of ATP, or dysfunctional quality control
mechanisms, the balance is tipped and the remaining (L)-Opa1 are cleaved by Oma1
resulting in mitochondrial fragmentation [64-68]. Mitofusins are regulated mainly by
ubiquitin-mediated degradation, specifically through the PTEN-induced kinase (PINK1)
and Parkin-mediated ubiquitination pathway during mitophagy [69]. Abnormalities in
proteolytic cleavage of Opa1 or ubiquitination of the mitofusins result in impaired fusion,
changes in cristae architecture, and favor a fragmented mitochondrial phenotype.
2.2 Mitophagy: Out with the Old, In with the New
Mitophagy is thought to be carried out via two different mechanisms:
autophagosomal mitophagy and endosomal-mediated mitophagy (Fig. 1-3). Autophagy
is the catabolic process of cellular components including cytosolic protein aggregates and
organelles such as mitochondria that are sequestered in a double-membrane structure
called an autophagosome [70, 71]. There are three distinct subtypes of autophagy [72].
Macro-autophagy (typically referred to as autophagy) is the process of taking damaged
proteins and organelles from the cytoplasm to the lysosome for degradation via an
intermediate vesicle termed the autophagosome (summarized in Fig. 1-4). Macroautophagy typically involves the degradation of large cellular components such as
organelles through both selective and non-selective mechanisms. In contrast, in so-called
micro-autophagy, particles are directly taken up by the lysosome (no intermediate vesicle)
by direct engulfment where they are degraded. Lastly, chaperone-mediated autophagy
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involves targeting dysfunctional proteins to be taken across the lysosomal membrane with
the aid of the cytosolic chaperone heat shock cognate 70 kDa protein (HSC-70). The
protein-chaperone protein complex then interacts with a specific lysosomal membrane
receptor, lysosomal-associated membrane protein 2A (LAMP-2A), resulting in their
degradation [73, 74].
Endosomes are membrane bound organelles which are responsible for sorting
both extracellular and intracellular proteins, lipids, and solute [75]. There are three types
of endosomes which can be distinguished by morphology and protein markers such as
the Rab-GTPase proteins [75, 76]. Early endosomes (EEs) receive extracellular cargo
from several endocytic pathways and represent the main sorting compartment [77, 78].
They consist of highly dynamic tubular-vesicular networks and are mainly enriched with
Rab5, which plays a dual role in mediating the fusion of other EEs as well as maturation
of EEs to late endosomes via the recruitment of Rab7 [76, 77]. EEs sort extracellular
content within their tubular networks and generate vesicle carriers targeted to two distinct
fates: recycling to the plasma membrane or degradation via the lysosome [77, 79].
Recycling endosomes (REs) will shuttle the majority of extracellular content back to the
plasma membrane and are marked mainly with Rab4 and Rab35 (rapid recycling) or by
Rab11 (slow recycling) [80-86]. Late endosomes (LEs) are responsible for delivering
cargo targeted for degradation to the lysosome and appear spherical. The maturation of
EEs to LEs involve changes including the switch from Rab5 to Rab7 enrichment,
acidification, and the formation of intraluminal vesicles (ILVs) [77, 87-92]. ILVs are
responsible for the recognition and sequestration of ubiquitinated proteins while Rab7
enables the fusion of LEs to the lysosome [77, 93].
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Mitochondrial degradation through macroautophagy or endosomal-mediated
degradation has been termed mitophagy. Mitophagy occurs through several different
pathways (summarized in 1-6) that all involve: (i) detection of dysfunctional mitochondria,
(ii) segregation from the healthy mitochondrial network, (iii) recruitment of the phagophore
or early endosome, and (iv) degradation through fusion lysosomal processes. Mitophagy,
in concert with mitochondrial biogenesis, ensures a healthy mitochondrial network
through mitochondrial turnover. Clearance of dysfunctional mitochondria is critical to limit
cellular damage via ROS production and subsequent apoptosis. Mitophagic proteins,
specifically Parkin, are critical for eliminating mitochondria with deleterious mtDNA
mutations via mitophagy [20]. This suggests that mitophagy is selective and plays pivotal
role in the maintaining a functional population of mitochondria.

Fig. 1-3. The different fates of mitochondrial clearance. During pathophysiological conditions, clearance
of dysfunctional mitochondria can be carried out through autophagy (top) or the endosomal pathway
(bottom). Both pathways result in mitochondria-containing vesicles fusing with a lysosome for degradation.

2.3 Autophagy: The Four Phases
There are four phases in the development of an autophagosome: (i) nucleation, (ii)
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elongation, (iii) sequestration and maturation, followed by (iv) fusion and degradation (Fig.
1-4) [94, 95].
Nucleation of the isolation membrane is initiated first through the phosphorylation
of the Unc-51 Like Autophagy Activating kinase 1 (ULK1) complex, typically by 5’AMPactivated protein kinase (AMPK) [96]. Once phosphorylated, the ULK1 complex will recruit
several different autophagosome-related proteins (Atg) to the autophagosome formation
site. In addition, ULK1 also phosphorylates Beclin1 (Atg6) which, in turn, initiates the
activity of the class III phosphotidylinositol 3-kinase (PI3K) complex (Beclin1 and vacuolar
proteins sorting 34 and 15 (VPS34, and VPS15)) for nucleation of the phagophore [9698].
Elongation of the phagophore is mediated by two ubiquitin-like systems (ULS) [96].
In the Atg5-Atg12 conjugation system (first of the two ULS), Atg12 is activated by Atg7
(an E1-like enzyme) and is then transferred to Atg10 (an E2-like enzyme) that is on the
target protein Atg5. This Atg5-Atg12 will form a dimeric complex with Atg16, which will
target the phagophore membrane. The second ULS involves the cleavage of Atg8 by
Atg4 (cysteine protease) and, subsequently, the processing by the ubiquitin-like enzymes
Atg7 and Atg3 [96]. Together, these ULS, along with light chain 3 (LC3), extend the
autophagosome membrane.
Sequestration is the process by which the isolation membrane encircles the
damaged organelle. This is mediated through the binding of LC3 to a variety of different
proteins/receptors that detect damaged organelles [97, 99, 100]. LC3 is processed by a
cysteine protease to its cytosolic form, LC3I. Cytosolic LC3I then conjugates with
phosphotidylethanolamine (PE) associated with the inner and outer membrane of the
phagophore to form LC3II [101]. The phagophore will then continue to elongate until it

12
completely engulfs its cargo and matures into an autophagosome.
In the degradation phase, the autophagosome fuses with the lysosome, resulting
in the degradation of its cargo via acid hydrolase enzymes [94, 95]. In the fusion process,
soluble NSF attachment protein receptor (SNARE) proteins, endosomal coating proteins
(COPs), the endosomal sorting complex require for transport (ESCRT III) complex, the
homotypic fusion and protein sorting (HOPS) complex, LAMP proteins, GTPase Rab
proteins, the Beclin 1 binding protein Rubicon, and chaperon HSP70 family proteins have
all been implicated to play contributing roles [102-109]. More specifically, Chen et al.
reported that tectonin beta-propeller repeat-containing protein 1 (TECPR1) of the
lysosome binds phosphotidylinositol 3-phosphate upon conjugation of Atg12-Atg5 to
promote autophagosome-lysosome fusion [110]. After degradation, the cargo’s amino

Fig. 1-4. The phases of autophagy. Autophagy is carried out in four different phases: nucleation,
elongation, sequestration, and degradation. Nucleation of the isolation membrane is initiated by the
phosphorylation of the ULK1-complex by AMPK. ULK1 will then recruit several autophagosome-related
proteins for nucleation of the phagophore via phosphorylation of Beclin1 in the PI3K complex. Elongation
or the extension of the autophagosome membrane is mediated by two ubiquitin-like systems involving the
transferring of Atg12 from Atg7 to Atg10, and finally Atg5 where it forms a dimeric complex with Atg16 on
the phagophore membrane. LC3 is also thought to help mediate the extension of the phagophore.
Sequestration occurs when damaged organelles are detected via LC3/autophagy receptor interactions.
Autophagy receptors localized on damaged organelles will bind LC3 inducing elongation of the phagophore
until the cargo is completely engulfed and matures into an autophagosome. In the degradation phase, the
lysosome will fuse with the autophagosome (autolysosome), releasing acid hydrolase enzymes that
degrade the contents.
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acids and lipids can then be reused for synthesis of new organelles.
2.4 Endosomal-Mediated Degradation: Another Avenue for Degradation
Endosomal-mediated degradation is a cellular degradation process that
sequesters cellular components into ILVs through three distinct steps: i) identification and
recruitment t the endosome, ii) sequestration, and iii) degradation (Fig. 1-5) [77, 111]. The
endosomal sorting complex required for transport (ESCRT) complexes play critical roles
in this degradation pathway and are named in order of their recruitment: ESCRT-0,
ESCRT-I, ESCRT-II, and ESCRT-III.
Identification and recruitment to the endosome occurs through the interaction and
recruitment of ESCRT-0, ESCRT-I, and ESCRT-II to ubiquitinated proteins [111, 112].
ESCRT-0, which is composed of two subunits in mammalian cells, hepatocyte growth
factor-regulated tyrosine kinase substrate (Hrs) and signal transducing adaptor
molecule1/2
(STAM1/2), will i) bind
to

ubiquitinated

proteins,

ii)

bind

to

phosphatidylinositol 3phosphate
(PtdIns(3)P),

an

endosomal
recruit

lipid,

the

complex
endosome,

to

entire

to
and

the
iii)

recruit ESCRT-I to the

Fig. 1-5. The ESCRT pathway. Endosomal mediated degradation of
mitochondria is carried out in three phases: identification and recruitment,
sequestration, and degradation. Identification of ubiquitinated cargo is
mediated by ESCT-0. ESCRT-0 recruits ESCRT-I to the ubiquitinated
cargo where it binds to ubiquitin and recruits ESCRT-II. Recruitment of
the cargo to early endosomes is mediated by ESCRT-0 and ESCRT-II
through their PtdIns(3)P binding domains. ESCRT-II recruits and activates
ESCRT-III to induce sequestration. ESCRT-III oligomerizes around the
ubiquitinated cargo, recruits Vsp3/Vta1, and in a concerted fashion
mediate pore formation, ESCRT disassembly, and vesicle scission. In the
degradation phase, lysosomes will fuse with late endosomes, releasing
acid hydrolase enzymes that degrade the contents.
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endosome [111-115]. ESCRT-I, composed of tumor susceptibility gene 101 (Tsg101),
multivesicular body 12 (Mvb12), vacuolar sorting protein 28 (Vps28), and Vps 37 in
mammalian cells, will help bind ubiquitinated proteins and recruit ESCRT-2 [116-121].
Like ESCRT-0, ESCRT-II, composed of ELL-associated protein of 30kDa (EAP30),
EAP45, and EAP20, can also bind to ubiquitin as well as PtdIns(3)P, which help provide
endosomal localization [122-126]. In addition, ESCRT-2 plays a critical role in initiating
ESCRT-III assembly [111].
Sequestration is mediated by ESCRT-III and consists of four subunits of the
charged multivesicular body proteins (CHMPs): CHMP6, CHMP4, CHMP3, and CHMP2
[111, 127]. Once activated by ESCRT-II, CHMP6 nucleates the oligomerization of two
CHMP4 filaments around the ubiquitinated cargo in either a parallel or branched fashion
[128, 129]. CHMP3 provides the cap for the two CHMP4 filaments and recruits CHMP2
to complete ESCRT-III assembly [111, 128]. Once assembled, CHMP2 recruits Vps4, a
class I ATPase associated with various cellular activities (AAA), and vesicle trafficking1
(Vta1), which in a concerted process mediate pore formation, ESCRT disassembly, and
vesicle scission [111, 130, 131].
Similar to autophagy, degradation is marked by the fusion of LEs to lysosomes
and the resulting degradation of its cargo with acidic hydrolases [132, 133]. Along with
SNARE protein interaction, Rab interacting lysosomal protein (RILP) interacts with the
HOPS complex in a Rab7 dependent manner to mediate fusion of the lysosome [132,
134]. In addition, the interaction of RILP and Rab7 help regulate the assembly and
function of V-ATPase for acidification [135, 136]. Similar to autophagy, following
degradation, the cargo’s amino acids and lipids can be reused for synthesis of new
organelles.
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2.5 Identification of Dysfunctional Mitochondria: The Pathways of Mitophagy
Four pathways have been identified that detect dysfunctional mitochondria and
recruit autophagosomes for degradation (summarized in Fig. 1-6). The most well-known
pathway is PINK1/Parkin-mediated mitophagy [137, 138], named for its role in the
pathogenesis of Parkinson’s Disease. PINK1 contains a mitochondrial targeting domain
such that, in healthy mitochondria, it is: (i) transported into the inter-membrane space
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the
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into the inner mitochondrial
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Fig. 1-6. Mitophagic pathways. A) In dysfunctional mitochondria,
PINK1 accumulates in the outer mitochondrial membrane.
Accumulations of PINK1 induce a signaling cascade involving the
recruitment and phosphorylation of Parkin, ubiquitin, and TBK1.
Phosphorylation by PINK1 as well as phospho-Ser65-ubiquitin activates
Parkin and leads to ubiquitination of outer mitochondrial membrane
proteins. Phagophore recruitment and binding are then mediated by
OPTN and NDP52 with its ubiquitin and LC3 binding domains.
Additionally, ubiquitinated mitochondria can bind to early endosomes
via ESCRT complexes. B) BNIP3/Nix are localized on the outer
mitochondrial membrane and serve as mitophagy receptors and bind
directly to the phagosome via LC3. C) FUNDC1 localizes on the outer
mitochondrial membrane and acts as a receptor for mitophagy under
hypoxic condition. During hypoxia, PGAM5 dephosphorylates FUNDC1
and activates mitophagy via LC3 binding on the phagophore. D)
Cardiolipin localizes to the inner mitochondrial membrane, specifically
around the folds of the cristae. When cardiolipin is oxidized, it is
externalized to the outer mitochondrial membrane where it is
recognized by LC3 of the phagophore.
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concentration of PINK1 low [140]. However, TIM-mediated import of protein relies on a
steady mitochondrial membrane potential. When mitochondria are depolarized, PINK1
can no longer be inserted into the mitochondria, inhibiting its proteolytic cleavage and
subsequent degradation [141]. PINK1 then accumulates on depolarized mitochondria,
where it phosphorylates and activates a myriad of proteins including Parkin, ubiquitin, and
TANK binding kinase 1 (TBK1) [137, 142-146] (Fig. 1-6A).
Parkin is an E3 ubiquitin ligase that is activated by phosphorylation by PINK at
Ser65 within its ubiquitin like domain [147, 148]. In addition, Parkin has also been reported
to be activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 [144, 146, 149].
When activated, Parkin will ubiquitinate numerous outer mitochondrial membrane
proteins including mitofusins and voltage dependent anion channel (VDAC) [69, 150,
151]. Interestingly, the ubiquitin chains generated by Parkin are major targets of PINK1
phosphorylation, allowing Parkin retention on mitochondria, providing a feed-forward
mechanism to promote mitophagy [143, 149]. Concurrently, PINK1 also phosphorylates
TBK1 at Ser172, promoting the phosphorylation of three different autophagy adaptor
proteins: p62 (also known as sequestrome 1 (SQSTM1)), optineurin (OPTN), and nuclear
dot protein (NDP52) [152-154]. The aggregation of dysfunctional mitochondria is
mediated via p62, while OPTN and NDP52 serves as receptors for the phagophore via
ubiquitin and LC3 binding domains in autophagosomal mitophagy[153-158] (Fig. 1-6A).
Histone deacetylase 6 (HDAC6) will also translocate upon ubiquitination of outer
mitochondrial membrane proteins and has been shown to enhance fusion of the
autophagosome and lysosome [159, 160]. Likewise, in endosomal-mediated mitophagy,
ESCRT complexes on EEs will recognize and capture Parkin ubiquitinated mitochondria
[161, 162]. ESCRT machinery then internalizes the captured mitochondria via
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invagination and subsequent scission of the endosome membrane [161, 162]. EEs
containing mitochondria mature into LEs and fuse with lysosomes to finalize degradation.
Additionally, recent evidence suggests that TBK1 may play a role in promoting PINK1Parkin endosomal-mediated mitophagy through the direct phosphorylation of Rab7a
[163]. Whether TBK1 phosphorylation of Rab7a drives mitophagy or is a downstream
effector of mitophagic processes still remains to be elucidated.
Mitophagy can also be regulated in a receptor-mediated fashion. One of these
pathways is through BNIP3/NIX, which are B-cell CLL/Lymphoma 2 (BCL-2) related
proteins. These proteins play a dual role by both: (i) inducing mitochondrial apoptosis,
and (ii) localizing to the mitochondrial membrane and acting as autophagy receptors
where they can directly bind to LC3 [164-168] (Fig. 1-6B). This pathway is distinct from
the PINK1/Parkin-mediated mitophagy in that PINK1/Parkin requires depolarized
mitochondria to initiate mitophagy, whereas BNIP3 can activate mitophagy in
mitochondria that have a stable membrane potential [137, 138, 169]. BNIP3 does recruit
Parkin to mitochondria, and it has been shown that Parkin-deficient myocytes display a
reduction in mitophagy despite overexpression of BNIP3 [170]. Although these proteins
have dual function in activating mitophagy or inducing apoptosis, it is unclear how they
are recruited for each divergent role.
FUNDC1 (FUN14 domain containing 1) is an outer mitochondrial membrane
protein that mediates mitophagy through receptor binding with LC3 and has been
implicated to play a role in hypoxia-mediated mitophagy [171] (Fig. 1-6C). FUNDC1 is
regulated by (casein kinase 2 (CK2) and the mitochondrial serine/threonine protein
phosphatase PGAM5 [172]: specifically, CK2 phosphorylates FUNDC1 to inhibit its
function while, during hypoxia, PGAM5 phosphatase dephosphorylates FUNDC1 to
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activate its binding to LC3 and thus promote mitophagy. This pathway has been shown
to be related to both PINK1/Parkin and BNIP3 primarily through PGAM5. PGAM5
phosphatase activity is required for PINK1 stabilization as well as PINK1/Parkinmediated mitophagy, and PGAM5 deficient mice develop Parkinson’s Disease [173].
BNIP3 has also been shown to be activated in hypoxia and induce mitophagy [174].
Whether or not these three pathways communicate with one another is still a question
that needs further investigation.
Cardiolipin is a lipid predominantly localized to the inner mitochondrial membrane,
is involved in mitochondrial metabolism and, interestingly, has also recently been
implicated in receptor-mediated mitophagy [175, 176]. When oxidized, cardiolipin
undergoes redistribution and externalization to the surface of damaged mitochondria
where it is recognized by LC3 [176] (Fig. 1-6D). Nucleoside-diphosphate kinase-D
(NDPK-D (NM23-H4)), a hexameric intermembrane space protein, mediates the
externalization of cardiolipin in artificially depolarized mitochondria [177]. How this
process may interact with the PINK1/Parkin pathway is still unknown, but may provide
novel insight to a potential role for cardiolipin signaling in pathologies involving
mitochondrial membrane depolarization that occurs during I/R injury.
2.6 Mitochondrial Biogenesis
Mitochondrial biogenesis refers to the growth and division of pre-existing
mitochondria. After mitochondria are degraded, the existing mitochondrial pool needs to
continue growing to keep pace with energy demands of the cell. The increase in
mitochondrial content involves an array of processes that include protein and lipid
synthesis driven by both nuclear and mtDNA transcription. The double-stranded circular
mtDNA is about 16.5 kb in length and contains 37 genes that encode for 13 proteins
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(subunits of electron transport chain complexes), 22 transfer RNAs, and 2 ribosomal
RNAs necessary for translation [178]. Similarly, lipids such as phosphotidylethanolamine,
phosphotidylglycerine, and cardiolipin are synthesized within the mitochondria from ERderived phospholipids [179]. The rest of the ~1000 proteins and lipids come from the
nucleus and ER, respectively. This coordinated import and synthesis of proteins and lipids
are essential for healthy mitochondrial biogenesis.
Peroxisome proliferator-activated receptor co-activator (PGC-1) is considered to
be the primary regulator of mitochondrial biogenesis [180]. PGC-1 is induced under
conditions of increased energy demand such as fasting, cold, and exercise where it
increases the expression of, and co-activates, a variety of transcription factors [180-183].
These transcription factors include the nuclear respiratory factors (NRF1/2), peroxisome
proliferator-activated receptor (PPAR), as well as estrogen-related receptors (ERR) [180].
NRF1 and NRF2 promote the expression of the nuclear encoded mitochondrial
transcription factor A (Tfam), which is responsible for the transcription of mtDNA [184].
As described previously, mtDNA gives rise to 13 subunits of the electron transport chain
as well as the 22 tRNAs and 2rRNAs. The nuclear proteins come from the transcriptional
activity of PPARs and ERRs, which are involved in regulating the expression of proteins
and enzymes that control multiple aspects of mitochondrial oxidative metabolism ranging
from fatty acid transport and oxidation, glucose utilization, the TCA cycle, to oxidative
phosphorylation [185]. Once transcribed in the nucleus, the mRNA is then translated in
the cytosol complete with a mitochondrial localization signal. The proteins are
subsequently transported in an unfolded fashion with the aid of molecular chaperones
such as Hsp70 and inserted into the mitochondria through protein translocases, including
TOM and TIM (both involved in the translocation of PINK1), as well as presequence
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translocase-associated motor (PAM), and sorting and assembly machinery (SAM) [186].
Lipids, on the other hand, are primarily synthesized in the ER and transported to
the mitochondria during biogenesis [187]. The transfer of primarily phospholipids [188]
from the ER to mitochondria has been thought to be mediated via ER-mitochondrial
contacts, effectively termed the mitochondria-associated membranes (MAMs) [189]. The
MAMs are purportedly comprised of a variety of proteins including: (i) the IP3 receptor
and VDAC1, through Grp75, that play a role in calcium signaling, (ii) the mitofusins,
expressed both on mitochondria and ER membranes, that play a role in tethering and
modulating mitochondrial dynamics, (iii) the ER stress sensor PERK that initiates
signaling in response to ER stress, and (iv) many more [190-192]. Although it remains
unclear how lipids are transported in MAMs, in yeast it is thought that ER-mitochondrial
encounter structure (ERMES) are responsible [193]. ERMES are composed of the
structural

components

maintenance

of

mitochondrial

morphology

1

(MMM1),

mitochondrial distribution and morphology 34 (Mdm34), Mdm12, and Mdm10 as well as
a the regulatory subunit GTPase EF-hand protein of mitochondria (Gem1) [194]. The
ERMES complex possesses a synaptotagmin-like mitochondrial-lipid-binding (SMP)
domain that harbors an elongated hydrophobic groove in which different lipids can bind
and possibly be transported [195]. Once the lipids are transported from the ER,
mitochondrial enzymes can then synthesize the lipids critical for mitochondrial function.
2.7 The Interplay Between Mitochondrial Dynamics and Mitophagy
Mitochondrial dynamics and mitophagy have been thoroughly examined individually,
but investigations aimed at elucidating the interplay between these two components of
mitochondrial quality control have been limited. It has been shown that fission can trigger
mitophagy and govern mitochondrial clearance [18, 196]. In this regard, multiple studies
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have demonstrated that alterations to pro-fusion or pro-fission proteins can affect
mitophagy: i.e., inhibition of Fis1 in insulin secreting (INS1) cells resulted in a 70%
reduction of mitophagy, while overexpression of Drp1 in HeLa cells was accompanied by
a 70% decrease in mitochondrial mass [196, 197]. Further evidence that fission and
mitophagy are intimately associated is that the Drp1-dependent mediator of fission,
endophilin B1, colocalizes with autophagic markers LC3, Atg5, and Atg9 specifically in
response to nutrient starvation [198, 199].

Conversely, proteins associated with

mitophagy (in particular, excessive PINK1 in depolarized mitochondria) may also play a
role in fission by mechanisms that are, at present, unclear. It has been proposed that
when PINK1 accumulates and recruits Parkin, Parkin ubiquitinates mitofusins to inhibit
fusion [17]. Accordingly, in a state where all mitochondria are depolarized with PINK1
accumulation and mitofusin ubiquitination, the only path for mitochondria would be fission.
However, although fission is apparently necessary for mitophagy, mitophagy is not
necessary for fission [69, 137, 170, 196, 200, 201].
3. Mitochondrial Quality Control in Disease
As discussed in the previous sections, mitochondrial dynamics and mitophagy are
essential regulators of mitochondrial quality control and play a role in maintaining
mitochondrial homeostasis in healthy cells. Defects in mitochondrial quality control have
also been implicated to contribute to both chronic and acute neurological and
cardiovascular diseases; however, little is known about how mitochondrial dynamics and
mitophagy interact/communicate with each other under pathophysiological conditions.
3.1 Chronic Diseases: Parkinson’s and Alzheimer’s Disease
3.1.1 Parkinson’s Disease
The pathologic signature of PD is the accumulation of damaged protein aggregates
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such as α-synuclein (SNCA) and ubiquitin into intracytoplasmic inclusions termed Lewy
bodies. PD has been associated with mutations, sporadic or hereditary, in at least 6
genes that are responsible for generating mutations that encode the following proteins:
SNCA, Parkin, β-glucocerebrosidase (GBA), PINK1, the protein deglycase DJ1, and
leucine-rich repeat kinase 2 (LRRK2) [202].

Interestingly, these genes give rise to

proteins that are associated with mitochondria or located within mitochondria, thereby
implicating mitochondria as key players in PD [203-206]. Evidence of mitochondrial
abnormalities in PC (including reduced complex I activity, reduced mitochondrial
membrane potential, increased ROS production, altered mitochondrial dynamics,
impaired mitochondrial trafficking, and increases in mtDNA mutations) underscore this
association [207-211].
To maintain a healthy mitochondrial network, cells must undergo mitophagy to
dispose of damaged and dysfunctional mitochondria and produce new healthy
mitochondria via mitochondrial biogenesis. In PD, patients with PINK1 and Parkin
mutations display impaired mitophagy. Mutations and defects in PINK1: (i) have the
potential to diminish both the mitochondrial translocation and activation of Parkin, (ii) can
result in the failure to segregate dysfunctional mitochondria for mitophagy via fission
[212], and (iii) have been associated with a decrease in phospho-Drp1 levels and an
increase in Drp1 GTPase activity, suggesting a direct role of PINK1 to induce fission [213].
PINK1 deficiency has also been shown to be associated with dysfunctional Na+/Ca2+
exchangers in the inner mitochondrial membrane that cause unbalanced mitochondrial
calcium homeostasis [208]. This impairment of calcium efflux from the mitochondria
results in reduced respiration from ROS-stimulated inhibition of glucose uptake. Finally,
and not surprisingly based on the aforementioned associations, mutations in PINK1
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reportedly increase the sensitivity of cells to stress-induced cell death. Studies have
shown that PINK1 is necessary for long-term survival of cells [203, 214].
Mutations in Parkin, on the other hand, can lead to impaired ubiquitination of outer
mitochondrial membrane proteins, which has been shown to play a role in recognition by
the autophagosome [215]. Interestingly, Parkin was first linked to the mitochondria by
evidence that the protein prevented mitochondrial swelling and cytochrome C release in
cells treated with ceramide [216]. In addition to this purported neuroprotective role, Parkin
was found to protect mtDNA from oxidative stress and stimulate mtDNA repair systems
[217], while, in strains of Parkin knockout mice, neurons in the ventral midbrain displayed
severe mitochondrial damage and decreases in complexes I and IV, despite being devoid
of the phenotypical motor impairment characteristic of PD [218, 219]. It remains unclear
how deficiencies in Parkin lead to severe mitochondrial damage and PD. Mitochondria do
undergo a basal level of “wear and tear” via mtDNA mutations as well as oxidation of
lipids and proteins. As discussed previously, under normal conditions, these damaged
mitochondria would be sequestered and undergo proteolytic degradation. If, in PD,
defects in PINK1 and Parkin compromise the ability of the cell to degrade and dispose of
proteins or damaged mitochondria, the accrual of damaged organelles would, in all
likelihood, ultimately lead to cell death.
3.1.2 Alzheimer’s Disease
AD currently affects 1.5 million Americans, with the associated memory loss and
decline in cognitive function attributed to the accumulation of amyloid-β plaques and
phosphorylated tau [220]. Sporadic and hereditary AD are attributed to mutations in
several genes, as well as accumulation of mtDNA mutations that generally lead to an
increase in β-amyloid levels in the brain [221, 222]. Although the underlying mechanisms
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are unclear, accumulation of amyloid-β in neurons and formation of plaques has been
attributed to excessive cleavage of amyloid precursor protein (APP: a transmembrane
glycoprotein) or mutations in the apolipoprotein APOE4, which, under normal conditions,
contributes to the breakdown of amyloid-β [223] [224].
Early in the pathogenesis of AD, mitochondrial abnormalities are also common,
including defective glucose metabolism, a reduction in enzyme activity, mitochondrial
DNA mutations, defected gene expression, and aberrant mitochondrial dynamics [225].
Mitochondria in AD patients have been observed to reveal significant structural damage
together with decreases in mitochondrial fusion proteins, increases in Fis1, and increases
in Ser616 phosphorylated Drp1(despite decreases in total Drp1) – all of which favor
excessive fragmentation [226, 227]. In vitro studies corroborated this concept: i.e.,
overexpression of APP in M17 cells was associated with mitochondrial fragmentation,
reduced neurite growth, abnormal mitochondrial distribution, and modulation of
mitochondrial fission/fusion proteins [228]. Similar findings were obtained in primary
neurons of transgenic mice expressing the human APP Swedish mutation [229]. The
interactions between amyloid-β and Drp1 are still unknown, but limited data have
proposed GSK3β may be the mediator in Drp1 phosphorylation via the association of
amyloid-β with NMDA receptors and the Wnt signaling pathway [230]. With excessive
fission, healthy mitochondria are cleaved unnecessarily, thereby disrupting the
equilibration of mitochondrial matrix metabolites (required for efficient production of ATP)
and making the mitochondria more vulnerable to injury. In addition, this excessive
fragmentation could potentially lead to an upregulation in mitophagic pathways.
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4. Insights into I/R Injury
4.1 Fission, Fusion and Cell Fate
There has been growing interest in mitochondrial dynamics, and its potential
association with apoptosis, in the setting of I/R injury [231-234]. Several studies have
uncovered excessive mitochondrial fission or fragmentation during both ischemia and I/R
injury [235-238]. Using a 6-hour OGD model to simulate ischemia, Kim et al. observed a
massive mitochondrial fragmentation profile during OGD in H9C2 cells [235]. This
mitochondrial fission profile was confirmed in vivo using a 24-hour left anterior descending
permanent ligation model in mice [235]. Disatnik et al. and Ong et al. observed
mitochondrial fragmentation during reoxygenation in OGD/reoxygenation models using
neonatal primary cardiomyocytes and HL1 cells respectively [237, 238]. In the brain, Tang
et al. also demonstrated a highly fragmented mitochondrial profile in mouse N2a
neuroblastoma cells following OGD/reoxygenation [236]. Previous studies from our lab,
conducted using both primary rat neurons and HT22 cells, revealed evidence of
mitochondrial fission during OGD and reoxygenation [239]. Moreover, mitochondrial
fragmentation was accompanied by Opa1 processing and concomitant release of
cytochrome C [239]. Using an in vitro real time imaging model of OGD/reoxygenation, we
further observed complex temporal alterations in mitochondrial morphology [240]. Using
HT22 cells transfected with a plasmid containing a GFP-marker, two distinct phases of
fragmentation were detected: the first phase of fission occurred during OGD, while
reintroduction of oxygen triggered initial fusion followed by complete and massive
fragmentation after late reoxygenation. The massive fragmentation observed during late
reoxygenation was confirmed in vivo in CA1 hippocampal neurons of rats exposed to
global brain ischemia/reperfusion [240] .
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The aforementioned studies suggest that mitochondrial fragmentation is a
pathophysiological consequence of I/R injury and that inhibition of mitochondrial
fragmentation may reverse this. Indeed, in support of this concept, there is evidence that,
after exposure to apoptotic stimuli, Drp1 inhibition or overexpression of a dominant
negative Drp1 blocked the induction of apoptosis [241]. Moreover, inhibition of Drp1 was
found to be neuroprotective in response to OGD in vitro and transient focal ischemia in
vivo [242], and cardioprotective in cultured HL-1 cardiomyocytes subjected to OGD and
reoxygenation [243]. However, in the latter study, cardioprotection was only seen when
inhibition of Drp1 was initiated as a pretreatment; cell death was paradoxically
exacerbated when treatment was administered during reoxygenation [243]. This points to
the complexity of mitochondrial dynamics and its effects on cell death or survival – an
issue that is highlighted by observations that fusion (presumably favoring survival)
involves the formation of lipidic pores that may contribute to mitochondrial
permeabilization and compromise cell viability [244], while fission (as discussed above,
associated with cell death) is necessary for mitophagy and governs clearance of
dysfunctional mitochondria [18, 196]. Thus, despite strong evidence to suggest that
mitochondrial fragmentation can be detrimental to the cell during stress conditions,
collectively these results reveal a complex dynamic nature of mitochondria that requires
further study to understand (i) why fission occurs during these stress states (ii) why
inhibition of mitochondrial fission is only cardioprotective when initiated before the
OGD/ischemic event and (iii) why fusion is not possible after reoxygenation/reperfusion.
4.2 Mitophagy and I/R injury
I/R injury has been shown to activate mitophagy pathways through multiple
signals. During the ischemic phase when ATP production halts, AMPK pathways are
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upregulated to initiate autophagy [245]. AMPK activates ULK1 via phosphorylation, which
will activate the class III PI3K complex (Beclin1, VPS34, and VPS15) that initiate
nucleation of the phagophore [246]. Interestingly, ULK1 may have a redundant role in
activating mitophagy: i.e., has also been shown to translocate to mitochondria and
activated the FUNDC1 receptor [247]. During the reperfusion phase, ROS serves as a
signaling molecule to inhibit the mechanistic target of rapamycin (mTOR) pathways,
thereby contributing to the initiation and nucleation of the autophagosome [248]. ROS has
also been shown to activate mitophagy via BNIP3 although, as stated previously, high
levels of BNIP3 can induce apoptosis [249, 250]. Overexpression of BNIP3 in HL-1
myocytes was reported to increase cell death in response to simulated I/R injury by
facilitating mPTP opening through the activation of Bcl-2-asscoaited X protein (Bax) [164,
250]. Moreover, BNIP3-/- mice subjected to 1 hour coronary artery occlusion and 3 week
reperfusion exhibited preserved left ventricular (LV) systolic function and diminished LV
dilation, while conditional overexpression of BNIP3 reversed these effects, resulting in
increased apoptosis and infarct size [251]. Collectively, these results demonstrate a
threshold for BNIP3, as increases or overexpression will inevitably lead to increased
apoptosis. Given the dual “life-or-death” role of mitochondria, together with reports of the
strong association between mitophagic proteins (ie. BNIP3 and Drp1) and programmed
cell death, this raises the question of whether mitophagy is beneficial or detrimental to
cell fate in response to I/R injury.
4.2.1 Heart
During ischemia, up-regulation of mitophagy is agreed to confer protection [252,
253]. The most compelling evidence is provided by Kubli et al. Using an in vivo mouse
model, the investigators demonstrated that Parkin deficient mice are more sensitive to
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myocardial infarction [253]. Following permanent left anterior descending coronary artery
occlusion, Parkin deficient mice displayed accumulation of swollen and dysfunctional
mitochondria due to impaired mitophagy, which resulted in larger infarcts and reduced
survival rates [253]. Moreover, the investigators observed up-regulation of mitophagy with
increased expression of Parkin at the border zone of the infarct in wild-type mice [253].
In vitro studies corroborated this concept: i.e., overexpression of Parkin in isolated
cardiomyocytes subjected to hypoxia-mediated cell death was associated with increased
Parkin translocation to the mitochondria and increased cell viability, while cardiomyocytes
expressing Parkinson disease-associated mutants of Parkin failed to reduce hypoxiamediated cell death [253]. In accordance with this concept, evidence in the in vivo mouse
model of permanent coronary ligation revealed that the up-regulation of mitophagy via the
genetic deletion of two molecular inhibitors, p53 and TP53-induced glycolysis and
apoptosis regulator (TIGAR), attenuated apoptotic cell death and provided resistance to
subsequent remodeling [252]. Moreover, cardioprotection was reversed in p53-/- and
TIGAR-/- mice following permanent myocardial infarction with administration of
chloroquine, an autophagy inhibitor, an effect characterized by the accumulation of
abnormal mitochondria in the ischemic myocardium [252]. Interestingly, the up-regulation
of mitophagy via inhibition of p53 and TIGAR was induced through an increase in ROS
production followed by BNIP3 activation [252]. In this case BNIP3 activation was
necessary and beneficial in attenuating cardiac I/R injury.
In contrast to ischemic injury, the role of mitophagy in I/R injury remains
controversial. A considerable body of evidence suggest that an up-regulation of
mitophagy during myocardial I/R injury is protective [166, 254-256]. It was first described
that
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ischemia/reperfusion by Hamacher-Brady et al [256]. The investigators observations
revealed that autophagosomal engulfment of mitochondria was a prominent response in
their model. Subsequent studies using HL-1 cells demonstrated an upregulation of
BNIP3-regulated mitophagy following simulated I/R [166]. Purportedly, overexpression of
BNIP3 during simulated I/R induces mitochondrial damage via ROS production, leading
to an up-regulation of mitophagy [166]. Expression of ATG5K130R, a dominant negative
of ATG5 shown to suppress vacuole formation, significantly reduced mitophagy and
increased BNIP3-induced cell death [166].

Together, these data suggest that up-

regulation of mitophagy occurs following BNIP3 induced mitochondrial damage as a
cellular response to remove damaged mitochondria during I/R [166]. More recently, using
Langendorff heart I/R model, Lu et al. observed that PGAM5 deficient mice had
exacerbated necroptosis in response to 25 minutes of ischemia followed by 90 minutes
of reperfusion [254]. Data in their mouse embryonic fibroblasts (MEF) model of ROSdependent necroptosis revealed impaired autophagic removal of LC-3II as well as
impaired mitochondrial clearance following 24 hours of TNF- cycloheximide and z-VADfmk (TCZ) stimulation. Finally, up-regulation of mitophagy has been reported to play a
role in the gold standard of cardioprotection, ischemic preconditioning (IPC) [255]. In both
Langendorff perfused rat hearts and in vivo mice subjected to regional IPC, Parkin and
P62 translocate to the mitochondria and mediate mitophagy [255]. Moreover, IPC is
abolished in Parkin-deficient mice, suggesting a critical role for Parkin in IPC [255]. The
investigators propose that selective mitophagy of mitochondria that have the lowest
threshold for mPTP opening during IPC would leave behind mitochondria that are more
equipped to handle sustained ischemic insults [255].
In contrast to the aforementioned studies, there is some evidence to suggest that
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the suppression of mitophagy may protect the heart from I/R [257]. In a rat model of left
anterior descending coronary artery occlusion, pre-treatment with mitochondrial aldehyde
dehydrogenase 2 (ALDH2), an allosteric tetrameric enzyme responsible for the
metabolism or detoxification of toxic aldehydes, conferred cardioprotection via
attenuation of apoptotic cell death [257]. In vitro studies corroborated this concept using
H9C2 cells subjected to 2 hours of hypoxia (1% oxygen) and 1 hour of reoxygenation
[257]. Pre-treatment of ALDH2 increased cell viability through the suppression of
mitophagy [257]. Mitophagy was measured through co-localization of PINK1, Parkin, and
the mitochondrial electron transport chain protein cytochrome C oxidase subunit IV
(COXIV) [257]. However, given that mitophagy is in constant flux and mitochondria are
degraded in autophagolysosomes, mitophagy proteins such as PINK1 and Parkin that
are associated with dysfunctional mitochondria would also be degraded. Therefore,
evaluation of the mitophagic flux would aid in confirming that ALDH2 is suppressing
mitophagy as opposed to enhancing mitophagy and subsequently breakdown of
mitophagy proteins.
4.2.2 Brain
There are notable differences between brain and heart in that controversy lies with
respect to the role of mitophagy in ischemia as well as I/R (beneficial or detrimental).
Cerebral ischemic preconditioning has been associated with increased autophagosome
formation and confers neuroprotection in rats subjected to permanent middle cerebral
artery occlusion (pMCAO) [258]. More recent evidence in the same model of pMCAO
confirmed that the up-regulation of autophagy during ischemia includes mitophagy,
revealed by increased autophagic vacuoles containing mitochondria and LC3 colocalization with COXIV [259]. Interestingly, the up-regulation of mitophagy was mediated
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through Drp1 as treatment with Mdivi, a pharmacological inhibitor of Drp1, prevented
mitophagy and resulted in decreased LC3 and COXIV co-localization, increased levels of
mitochondrial proteins, and the accumulation of damaged mitochondria following 1 hour
of pMCAO [259]. Moreover, Drp1 inhibition exacerbated mitochondrial-mediated brain
injury to an even greater extent compared to the inhibition of autophagy using 3-MA
following 24 hours of pMCAO [259]. Conversely, in mice subjected to pMCAO,
administration of 3-MA conferred neuroprotection via a reduction in infarct size along with
a dose-dependent increase in cell viability following exposure of 4 hour OGD in rat primary
cortical neurons [260]. Knockdown of Atg7 with siRNA reinforced this concept, resulting
in increased cell viability in response to ischemia-induced neuronal injury [259].
Interestingly, the investigators observed no change in infarct volume with administration
of mdivi in both in vitro and in vivo models of ischemia [260]. The lack of observable
change could be a result of when the inhibitor was administered, i.e. at the point of artery
occlusion or the beginning of OGD. Results from our lab demonstrate that mitochondria
undergo massive fragmentation within 20 minutes of ischemia [240]. In this case,
mitochondrial fragmentation could have occurred before the onset of inhibition with mdivi,
resulting in segregated mitochondria ready to be recruited for mitophagy.
In cerebral I/R, there is a consequential amount of literature that suggests an upregulation of mitophagy confers neuroprotection [254, 260-262]. The strongest evidence
to support this concept is provided by Zhang et al [260]. Using pharmacological and
genetic suppression of autophagy (i.e. 3-MA treatment, Bafilomycin A1 (BafA) treatment,
Atg5 knockout, and Atg7 knockdown), primary cortical neurons subjected to 2 hours of
OGD followed by a 24-hour reperfusion had significantly decreased cell viability as
compared to controls [260]. These results were affirmed in an in vivo transient MCAO
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model, where inhibition of autophagy via 3-MA treatment and Atg7 knockdown
exacerbated I/R injury [260]. Moreover, addition of rapamycin, a known enhancer of
mitophagy that attenuates mitochondrial dysfunction following cerebral ischemia [261],
partly reversed the deleterious effects of 3-MA treated primary neurons subjected to
OGD-reperfusion [260]. Similar to heart, PGAM-/- mice subject to transient MCAO
displayed significantly higher infarct sizes as compared to wild type mice after 72 hours
of reperfusion [254].
At variance with the preceding studies, evidence provided by Shi et al. suggests
that excessive mitophagy following cerebral I/R results in cell death [263]. Using an
adapted Rice-Vanucci model of neonatal stroke or hypoxia-ischemia encephalopathy
(HIE), the investigators observed that pups deficient of BNIP3 had a decrease in
mitophagy that resulted in significantly smaller infarct sizes in response to neonatal stroke
and 7 days of reperfusion [263]. Interestingly, the infarct volume in BNIP3-/- pups was
significantly larger after 1 day of reperfusion, but then recovered while the infarct volume
in wild type pups was exacerbated after 3 to 7 days of reperfusion [263]. The investigators
also demonstrated in wild type pups, a dramatic increase in BNIP3 mitochondriallocalized homodimer expression in a time-dependent manner following neonatal stroke,
accompanied by a significant decrease in mitochondrial proteins from isolated cortical
neurons following 6 hours of OGD [263]. Although these data were collected in a neonatal
model, it suggests that i) BNIP3 induces excessive mitophagy following I/R, which
ultimately exacerbates cerebral I/R injury and ii) underscores the balance of mitophagy
required to prevent pro-apoptotic proteins such as BNIP3 to surpass the “death signal”
threshold.
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4.3 Beyond ‘Good’ Versus ‘Evil’: A Question of Balance?
As reviewed in the preceding sections, there is continued controversy regarding
whether upregulation of mitophagy in the setting of I/R is ‘good’ or ‘bad’. It may, however,
be more appropriate to consider mitophagy (and mitochondrial quality control as a whole)
as a balancing act (Fig. 1-7). For
example, it has been proposed
that,

following

reperfusion,

mitophagy is essential to clear
dysfunctional mitochondria [260].
However, excessive mitophagy
coupled

with

inhibited

mitochondrial biogenesis and a
global

decrease

in

protein

synthesis [264, 265] will result in
a decrease in mitochondrial mass
and, subsequently, a deficit in
ATP production that may fail to Fig. 1-7. Finding a balance of mitochondrial quality control.
meet the demands of the cell.
This energy imbalance could
eventually

cause

energy

deprivation and cell death. With
the other extreme – that is, with
minimal mitophagy – damaged
mitochondria

will

not

be

During I/R injury there is excessive mitochondrial fragmentation,
favoring an increase in mitophagy. Degradation of dysfunctional
ROS-producing mitochondria is critical for survival, however,
mitochondrial content decrease would compromise ATP
production. Insufficient ATP production paired with inhibited
biogenesis will ultimately lead to cell death. On the other hand,
if fission were completely inhibited, mitochondrial content would
be maintained, but damaged mitochondria would not be
segregated and could lead to accumulated mitochondrial
dysfunction. The increase in mitochondrial damage would
ultimately cause cell death. Therefore, a balance in
mitochondrial quality control (i.e., an equilibrium between
retaining adequate mitochondrial content for sufficient ATP
production versus disposal of dysfunctional mitochondria) is
optimal for cell survival after I/R injury.
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eliminated and the overall ROS burden would increase. This excessive ROS formation
could further induce mitochondrial dysfunction, leading to a feed-forward cycle of ROS
production and ultimately cell death (Fig. 1-7).
Accordingly, there is a fundamental need for balance in mitochondrial quality
control, and further investigation is needed to define this threshold. If this threshold can
be identified, modulation of mitophagy may represent a valuable therapeutic option, with
the goal of eliminating dysfunctional mitochondria while still providing sufficient energy to
repair cellular damage, restore protein translation, and ultimately return to homeostasis.
PINK1 and Parkin (rather than BNIP3 and NIX) may yield the greatest promise as
effective targets for manipulation of mitophagy, given their reported favorable association
with cell survival together with a lack of involvement in apoptotic pathways [253, 255,
260].
5. Conclusions and Challenges
Mitochondrial quality control is critical for the homeostasis of the mitochondrial
network, and a constant balance needed between mitochondrial fission/fusion as well as
mitophagy and biogenesis. Disruption of mitochondrial quality control has been proposed
to contribute to the pathogenesis of acute and chronic diseases, including Parkinson’s
Disease, Alzheimer’s Disease, and ischemia-reperfusion-induced cell death in brain and
heart. Accordingly, targeted modulation of one or more of the molecular components
involved in mitochondrial quality control provide opportunities for the design of novel
therapies. However, to capitalize on this potential opportunity, a greater mechanistic
understanding of mitochondrial fission/fusion, mitophagy and mitochondrial quality control
– together with the development of improved molecular tools to investigate these complex
phenomena [266] – will be required. To overcome these challenges, we have utilized
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novel mouse lines such as the mitoQC reporter mice to help visualize mitochondria
undergoing degradation in real time. In addition, we have developed a highly specific and
sensitive mitochondrial morphology classification system to precisely measure
mitochondrial dynamics through the duration of in vitro I/R injury. Together, this
dissertation aims to further elucidate the role of mitochondrial quality control in the context
of cerebral I/R injury.
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CHAPTER 2: METHODS
1. Animals (Chapters 4-6)
All experimental procedures were performed in accordance with institutional
guidelines and approved by the Institutional Animal Care and Use Committee under
protocol #IACUC-18-08-0767 at Wayne State University and under protocol
#PRO00009531 at the University of Michigan. Mitochondrial quality control (mitoQC)
reporter transgenic mice (C57BL/6-Gt(ROSA)26Sortm1(CAG-mCherry/GFP)Ganl/J)
were provided by Dr. Ian Ganley, University of Dundee, Scotland, UK [267]. Drp1 floxed
(Drp1fl/fl) mice (Dnm1ltm1.1Hise) were provided by Hiromi Sesaki, Johns Hopkins, Baltimore,
MD [268]. Wild Type (WT) mice (B57BL/6Crl) were purchased from Charles River
Laboratories.
2. Primary Cortical Neuron Isolation and Culture (Chapters 4-6)
Mouse pups were sacrificed by decapitation on postnatal day 0-2 (P0-P2). Heads
were soaked in ethanol for 30 seconds then brains were dissected in ice cold Dulbecco’s
phosphate buffered saline (DPBS). A midline incision was made to allow access to the
skull using a #10 stainless steel scalpel. The skull was resected away from the midline,
and the brain was extracted to isolate the cortex, a midline incision was made along the
the corpus callosum to isolate the cortex. Cortices were transferred to a 35 mm dish
containing hibernate complete medium (1X Hibernate-A medium (Gibco, A1247501), 2%
B27 supplement (ThermoFisher, 17504044), 0.5 mM Glutamax Supplement (Gibco,
35050061), and 1% Penn/Strep (Gibco, SV30010)). Brains were isolated, processed, and
seeded separately for individually biological replicates. Cortices were rolled over filter
paper to remove the meninges. Cortices were then cut into ~1-2mm pieces and
transferred into a 15 ml Falcon tube. Tissue was digested with enzyme digestion solution
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(1x hibernate complete medium, 0.06 mg/ml L-cysteine (Sigma, 778672), 1.4X10-4 N
NaOH (sigma, 43617), 10 ng/ml APV (2-Amino-5-phosphonopentanoic acid, Sigma, A5282), 50 ul of Papain (Worthington, LS 03126)) and incubated at 37°C for 30 minutes.
After 30 minutes, the tissue was washed with DPBS twice and replaced with hibernate
complete medium and the tissue was dissociated by pipetting up and down 25 times to
generate a cell suspension. Cell suspension was passed through a 40-micron strainer to
separate tissue debris. Cells were stained with a 1:1 mixture of cell suspension and
Trypan Blue and counted with a hemocytometer. Cells were seeded at 190,000 cells/cm2
and incubated for 30 min at 37°C in 5%CO2. After 30 min, media was replaced with
neurobasal complete medium (1X Neurobasal Plus medium (Gibco, A3582901), 2% B27
plus (Gibco, A3653401), 0.5 mM Glutamax Supplement (Gibco, 35050061), and 1%
Penn/Strep (Gibco, SV30010)) and cultured at 37°C in 5% CO2. Half-media changes
occurred every 3-4 days with neurobasal complete medium.
3. Oxygen Glucose Deprivation and Reoxygenation (OGD/R) (Chapters 4-6)
OGD was achieved utilizing the O2 Control InVitro Glove Box from Coy Lab
Products. The hypoxic chamber was maintained at 0.1% O2 and 5% CO2. OGD media
(0.20 g/L CaCl2 (Spectrum, CA138500GM), 0.4 g/L KCl (Fisher Chemical, P217-500),
0.097 g/L MgSO4 (Fisher Chemical, M65-500), 6.8 g/L NaCl (Fisher Chemical, S2711),
2.2 NaHCO3 (Acros Organics, AC447102500), 0.14 g/L NaH2PO4-H2O (Fisher Chemical,
S369-500, and 0.01 g/L Phenol red (Fisher Chemical, P74-10)) was bubbled with 95%
N2/5% CO2 inside of the of the hypoxic chamber for 60 min. Cells were transferred into
the hypoxic chamber, washed 2X with OGD media, and then incubated with OGD media
inside the hypoxic chamber for 180 min. After OGD, cells were taken out of the hypoxic
chamber, media was replaced with Neurobasal medium without antioxidants (complete
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neurobasal medium with B27 -AO (Gibco, 10889038)), and incubated in 37C 5% CO2 for
6 h.
4. Lentiviral Transduction (Chapter 6)
Cells were infected with lentivirus on DIV 7. Experiments were performed 7 days
post-transduction (DIV14). Lentiviral plasmids and Lentivirus were generated by the
vector core at the University of Michigan (Thomas Lanigan, PhD., Director): Lenti-EF1aCre-VSVG, Lenti-EF1a-VSVG, and Lenti-EF1a-GFP-VSVG. The EF1-alpha promoter,
possessing a broad host range, demonstrated robust, constitutive, and long-term
expression of both Cre-recombinase and GFP in our primary cortical neuron cultures (see
Chapter 6). Vesicular stomatitis Indiana virus G-protein (VSVG) envelope was used to
enhance viral entry. Viruses were made in a concentrated 10X form in Neurobasal
Medium. Titration curves were performed with Lenti-EF1a-VSVG and Lenti-EF1a-GFPVSVG to evaluate toxicity and transduction efficiency respectively. Toxicity was tested at
0.5X, 1X, 2X, 4X, and 5X concentrations. Transduction efficiency was tested at 0.5X and
1X concentrations.
5. MTT Assay (Chapter 6)
Viability was assessed after 2.5h of OGD followed by 6h of reoxygenation by
Thiazolyl Blue Tetrazolium Bromide (MTT) assay. MTT (5mg/ml in PBS, Acros Organics,
AC158992500) was added to cultures for a final concentration of 0.5 mg/ml and cells
incubated in 37°C 5%CO2 for 2h. Following the 2h incubation, media was removed and
replace with MTT solubilization solution (10% Triton-X100 and 12mM hydrochloric acid
(Fisher Chemical, A144SI-212) in Isopropanol (Fisher Chemical, A419-4)) and placed on
a shaker at room temperature for 15 min. 100 ul of each sample was then pipetted into a
96-well plate and analyzed for absorbance at 570 nm utilizing a PerkinElmer Multimode
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Plate Reader containing Enspire interface software.
6. Western Blot (Chapters 5-6)
6.1 Mitochondrial Isolation
To

obtain

mitochondria,

primary

cortical

neurons

were

collected

in

homogenization-A buffer and homogenized utilizing a Teflon Potter-Elvehjem
homogenizer (10 strokes at 300 rpm) (Thomas Scientific, 3432S90). Cell homogenates
were collected into Eppendorf tubes and centrifuged at 1,000 X g for 10 min at 4°C. The
supernatant (containing mitochondria and cytosol) was removed and placed into an
Eppendorf tube and centrifuged at 10,000 X g for 10 min at 4°C. The cytosolic supernatant
was removed, and the mitochondrial pellet was washed once with homogenization-A
buffer followed by another centrifugation at 10,000 X g for 10 min at 4°C. Mitochondrial
pellets were resuspended with fresh homogenization-A buffer and sonicated. Whole cell
pellets were saved and sonicated to be used as whole cell lysate samples.
6.2 Western Blot – General Methods
Protein homogenates were collected using homogenization-A buffer (10 mM
HEPES (pH7.5) (Sigma, H4034), 1 mM EDTA (Sigma, E6758), 1mM EGTA (Sigma,
03777), 100mM KCl (Sigma, P9333), 210 mM Mannitol (Sigma, M4125), 70 mM Sucrose
(Sigma, S0389), and 1X Halttm protease and phosphatase inhibitor cocktail
(ThermoFisher, 78440)). Homogenates for evaluating mitochondrial ubiquitination used
homogenization-A buffer with the addition of the proteasome inhibitor MG132 (5 uM,
Sigma, M7449). Cells were scraped off the plate and collected into a 1.5 mL Eppendorf
tube and sonicated. Protein concentration was measured via Bradford Plus Assay
Reagent (ThermoFisher, PI23236). Whole cell lysates were loaded with 10 ug of protein,
while mitochondrial samples were loaded with 5 ug of protein. Proteins were separated
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on polyacrylamide gels (10% 29:1 polyacrylamide/bisacrylamide (Fisher BioReagents,
BP1408-1), 375 mM Tris pH 8.8 (Fisher BioReagents, BP152-1), 0.1% sodium dodecyl
sulfate (SDS, Sigma, L3771), 0.1% ammonium persulfate (APS, Sigma, #A3678), and
0.1% TEMED (GE Healthcare, # 45-000-226)) and transferred to nitrocellulose
membranes at 100V for 90 min. Membranes were incubated with indicated primary
antibodies at 4°C overnight . Membranes were then washed 3X, 5 min each wash, with
Tris-Buffered Saline with 0.1% Tween (TBST, Fisher Scientific, BP337500) and incubated
with the indicated secondary antibodies for 60 minutes at room temperature. Membranes
were washed 3X with TBST, then incubated in SuperSignal West Pico Plus
Chemiluminescent Substrate (ThermoFisher, 34577) for 5 minutes. The membranes
were then imaged utilizing a BioRad ChemiDoc XRS + imager. Images were quantified
by densitometry using ImageJ software.
6.3 Western Blot – Antibodies
Dynamin like protein 1 (Dlp1/Drp1) (Clone 8) Mouse antibody (BD Transduction
Laboratories, BD611112, 1:1,000, 2% milk), Mono- and polyubiquitinylated conjugates
mouse monoclonal antibody clone FK2 (Enzo, BML-PW8810, 1:1,000, 5% milk), PINK1
Rabbit polyclonal antibody (Novus Biologicals, BC100-494, 1:1,000, 2% BSA), Parkin
(Prk8) mouse monoclonal antibody (Cell Signaling, 4211, 1:1,000, 2% milk), Rab5 (C8B1)
rabbit monoclonal antibody (Cell Signaling, 3547, 1:1,000, 5% BSA), VDAC (D73D12)
rabbit monoclonal antibody (Cell Signaling, 4661, 1:1,000, 2% BSA), GAPDH (14C10)
rabbit monoclonal antibody (Cell Signaling, 2118, 1:10,000, 2% BSA), LC3 A/B rabbit
antibody (Cell Signaling, 4108, 1:1,000, 2% BSA).
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7. Immunofluorescence (Chapters 4-6)
7.1 Immunofluorescence – General Method
Cells were fixed with 3.7% PFA (ThermoFisher, 50980487) in 200 mM HEPES
(Sigma, H4034) for 15 min at 37C. Coverslips were washed 3X with PBS and replaced
with blocking solution (5% goat serum (Sigma, G9023) and 0.3% Triton-X100 (Acros
Organics, 215682500) in PBS) for 60 min. Blocking solution was replaced with indicated
primary antibodies in antibody solution (1% BSA and 0.3% Triton-X100 in PBS) at 4°C
overnight. After primary incubation, coverslips were washed 3X in PBS and incubated
with indicated secondary antibodies in antibody solution for 60 min at room temperature,
covered from light. After secondary incubation, coverslips were washed 3X in PBS and
then mounted using Fluoroshield with DAPI (Sigma, F6057).
7.2 Immunofluorescence – Antibodies
MAP2 chicken polyclonal antibody (Abcam, ab5392, 1:1,000), Parkin rabbit
polyclonal antibody (ThermoFisher, PA5-13399, 1:50), PINK1 Rabbit polyclonal antibody
(Novus Biologicals, BC100-494, 1:100), Lamp1 (1D4B) rat antibody (Santa Cruz
Biotechnology, sc-19992, 1:100), PINK1 Rabbit polyclonal antibody (Novus Biologicals,
BC100-494, 1:100). Secondary antibodies were used donkey anti-mouse or donkey antirabbit HRP (Jackson Immuno Research Labs, NC9832458 and NC9736726), Alexa Fluor
488, Alexa Fluor 568, and Alexa Fluor 633 goat anti-rat (Life Technologies).
8. MitoQC Analysis (Chapters 5-6)
For each coverslip containing mitoQC neurons, 12 random photos were taken
utilizing a Zeiss Axio Observer.Z1 inverted microscope with a Colibri.2 module containing
4 LED based filter sets (49 DAPI: 365 nm excitation/445 nm emission, 38 HE GFP: 470
nm excitation/525 nm emission, 43 HE DsRed: 560 nm excitation/605 nm emission, and
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81 HE FR: 625 nm excitation/680 nm emission. DAPI channel contained a 160 ms
exposure at an intensity of 20%. GFP channel contained 160 ms at an intensity of 100%.
mCherry channel contained a 1300 ms exposure at an intensity of 100%. Far red channel
contained a 250 ms exposure at an intensity of 30%. Images were taken at a
magnification of 63X oil immersion. Each image was deconvolved using the regularized
inverse filter method on Zeiss Zen Pro software. Images were further processed in Fiji
ImageJ. The following was performed using FIJI’s (ImageJ) batch processing feature in
three separate phases: processing, segmentation, and red puncta analysis. The workflow
is listed below:
8.1 Processing:
-

Process > Subtract Background (Rolling Ball Radius = 10.0

-

Process > Filters > Unsharp Mask (Radius = 1.0 pixels, Mask Weight = 0.6)

-

Process > Enhance Local Contrast (block size = 127, histogram bins = 256
maximum slope = 3.00, mask = none, checkmark “fast” box)[269]

-

Process > Filters > Median (radius = 2.0 pixels

8.2 Segmentation:
Trainable Weka Segmentation was employed to segment red particles. Trainable
Weka Segmentation is a plugin in ImageJ that uses a combination of visualization tools
and machine learning algorithms to produce a pixel-based segmentation [270]. The
program was trained to segment “mitophagy” particles (red-only), “healthy mitochondria”
(green/yellow), and “background” (“black”). Once the classifier was trained, photos were
segmented using the category “probabilities” as an output.
8.3 Red Puncta Analysis:
-

Image > Stacks > Stacks to Image
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-

Close “Background” and “Healthy mitochondria” windows

-

Select window titled “Mitophagy

-

Image > Adjust > Threshold (0.31, 1x1031)

-

Process > Binary > Convert to Mask

-

Analyze > Set Scale (9.7 pixels/micron

-

Analyze > Analyze Particles (size = 0.0-Infinity, circularity = 0.0-1.0, show =
nothing, check summarize)
Results of red puncta counts were tabulated into an excel sheet for each image

and normalized to the number of cells analyzed.
9. Machine Learning Mitochondrial Classification (Chapters 4-6)
Machine learning-based classification of mitochondrial objects was performed in R
computing language using the R Caret package [271]. Fiji ImageJ was used for image
processing and mitochondrial object measurement collection. R studio was used for all
computation.
9.1 Feature Extraction
The green channel of the MitoQC images were used for mitochondrial morphology
analysis. Processing was done in the same workflow as above. Trainable WEKA
segmentation was employed to segment green mitochondrial signal using “Labels” as an
output. Segmented images were then analyzed to obtain measurements of each
mitochondrial object. Workflow is listed below:
-

Image > Type > 8-bit

-

Image > Type > 16-bit

-

Image > Type > 8-bit

-

Process > Binary > Make Binary
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-

Analyze > Set Scale (9.7 pixels/micron)

-

Analyze > Measure (if mean is </= 0.75 then invert (Edit > Invert), otherwise
continue)

-

BioVoxxel_Toolbox (ImageJ plugin) > Extended particle analyzer (Area = 0.3Infinity, Extent = 0-1, Perimeter = 0-Infinity, Circularity = 0-1, Roundness = 0-1,
solidity = 0-1, compactness 0-1, AR = 0-Infinity, Feret AR = 0-Infinity, Ellipsoid
angle = 0-180, Max Feret = 0-Infinity, Min Feret = 0-Infinity, Feret angle = 0-180,
Coefficient of Variation = 0-1, Show = Nothing, Redirect to = none, Keep borders
= none, check “display results”)
Measurements were then expanded using “extended descriptors” macro from the

Applied Superconductivity Center [272]. 32 measurements total were recorded for each
object: area, perimeter, circularity, feret, FeretAngle, Min Feret, aspect ratio (AR), Round,
Solidity, Feret AR, Compactness, Extent, CircToEllipse Tilt, AR_Box, AR_Feret,
Round_Feret, Compact_Feret, Elongation, Thinnes Ratio, Angle_0-90, Feret_Angle_090, Convexity, Roundness corrected to AR, area equivalent diameter, perimeter
equivalent diameter, spherical equivalent diameter, interfacial density, Hexagonal Side,
Hexagonal Perimeter, Hexagonal Shape Factor, Hexagonal Shape Factor Ratio, and
Hexagonality.
9.2 Random Forest Classifier
Hand classified mitochondrial objects (n=2342) containing the 32 measurements
(predictors) listed above were imported into R Studio as the train/test set. These objects
were

labeled

with

one

of

four

different

classifications:

networks

(n=236),

unbranched(n=851), swollen (n=458), or punctate (n=797). The data was then split based
off of their classifications into the training (80%) and the test (20%) sets using the
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createDataPatition function from the caret package [271]. A random forest algorithm (rf)
from the caret package was trained using the training set through 25 iterations utilizing
32 predictors. The final model consisted of 500 trees with an mtry = 2, which refers to the
number of randomly selected predictors considered at each split within the tree.
10. Statistical Analysis (Chapters 4-6)
Statistical analysis was performed using GraphPad Prism. PCA was done in R
using the built-in function prcomp(). Data is presented as means ± SEM. All experiments
were independently repeated in the lab and data were collected using 4-8 biological
replicates with 2-3 technical replicates for each experiment. Differences between three or
more groups were analyzed using either one-way ANOVA with either Tukey post hoc test
(for comparisons between all groups) or Dunnett’s post hoc test (when comparing groups
to just the control). Student’s t-test was used to detect differences between two groups.
Differences between conditions across time (Lenti-cre vs Lenti-empty) were analyzed
using a two-way ANOVA with Dunnett’s post-hoc analysis for differences across time
points compared to control. Multiple comparisons to detect differences between
conditions were computed using Sidak’s post-hoc test. Differences were considered
significant when p < 0.05.
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CHAPTER 3: STUDY OVERVIEW
As discussed in Chapter 1, ischemic brain injury caused by cardiac arrest and
stroke continue to be the leading causes of death and disability in the U.S. [273].
Mitochondria are key regulators controlling cell survival (via the production of ATP that
fuels cellular processes) or, conversely, cell death (via the initiation of programmed cell
death) [11, 13]. Therefore, it is imperative to have stringent quality control mechanisms in
place to ensure a healthy mitochondrial network. Mitochondrial quality control is carried
out through cellular processes that couple mitochondrial fission to the subsequent
removal of dysfunctional mitochondria via mitophagy. Establishing a balance between
mitochondrial fission/fusion is critical for the disposal of dysfunctional mitochondria that
may be potentially harmful to the cell, while maintaining the required amount of
mitochondrial content to fuel normal cellular processes. Pathological states, such as I/R
injury, disrupt these processes, tipping the scales to excessive fragmentation and
possibly upregulated mitophagy. The subsequent loss of mitochondrial content results in
insufficient energy production and ultimately cell death. Although these processes have
been a major focus of study in the context of I/R injury, quantitative investigation of
fission/fusion and mitophagy have been confounded by the dynamic nature of mitochondria.
Furthermore, it is poorly understood how i) the pathways of mitochondrial dynamics and
mitophagy interact with one another and ii) how disrupting mitochondrial quality control
mechanisms contributes to cell death during I/R injury. Given this background, my
dissertation will address the following objectives:
Objective 1: Develop a robust method to accurately and precisely measure
mitochondrial morphology during OGD/R in primary cortical neurons.
As reviewed in Chapter 1, it is well established that mitochondrial fragmentation
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observed during I/R injury is a pathological process associated with cell death. However,
most studies are limited in their characterization of mitochondrial morphology.
Morphology is typically classified as two different conditions: fused and fragmented.
Furthermore, these studies are either purely qualitative or use semi-quantitative scoring
system to profile mitochondrial morphology, both of which lack an accurate and precise
assessment of different mitochondrial morphologies that are physiologically relevant. In
order to overcome this, our goal was to develop a semi-automated machine learningbased classification system for mitochondrial objects. To accomplish this, we employed
ImageJ to measure all mitochondrial objects contained in a series of images and imported
that data into R studio to classify mitochondrial objects into four different categories
(networks, unbranched, swollen, punctate) using the “random forest” machine learning
algorithm. We then applied this classification system to mitochondria within primary
cortical neurons subjected to OGD/R. We hypothesize that mitochondria undergo
extensive remodeling following OGD/R, resulting in a fragmented morphology (see
Chapter 4).
Objective 2: Characterize mitophagic flux during OGD/R.
As reviewed in Chapter 1, there is evidence to suggest that mitophagy is
upregulated following I/R injury. However, whether upregulation of autophagy is beneficial
or detrimental to cell fate remains controversial. Historically, these studies measured
mitophagy through protein expression/translocation and colocalization of mitophagy
proteins as well as protein expression of mitochondrial content, thus limiting the ability to
accurately assess mitochondrial clearance. Furthermore, while mitophagy may be
inferred by measurements of mitochondrial content, it fails to provide any insight into the
events leading up to the actual clearance of mitochondria. To address these issues, we
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utilized the novel transgenic mito-QC reporter mice in an OGD/R model. The reporter
allele contains a CAG promoter and mCherry-GFP-mtFIS1 fusion protein inserted into the
Gt(ROSA)26Sor locus on chromosome 6. mCherry is stable in acidic pH (pKa 4.5) while
GFP (pKa 5.9) is quenched in the acidic lysosomal environment, allowing for identification
of mitochondria in autolysosomes. In addition, this model provides precise and temporal
resolution of mitophagic flux. We hypothesize that mitophagic flux is increased following
OGD/R (see Chapter 5).
Objective 3: Investigate the role mitochondrial dynamics on mitophagic flux during
OGD/R.
The final objective was to investigate how the mitochondrial fission protein Drp1,
regulates mitophagic flux following OGD/R. It is understood that mitochondrial fission is
necessary for mitophagy to occur, but less in known about the complex relationship
between mitochondrial dynamics and mitophagy and its role in maintaining cell viability
[18, 196]. To elucidate these mechanisms, Drp1 floxed (Drp1fl/fl) mice were crossed with
mitoQC reporter mice and used to study Drp1’s effect on i) mitochondrial dynamics, ii)
mitophagy, and iii) cell viability following OGD/R. We hypothesize that Drp1 significantly
alters mitochondrial quality control and increases cell viability (see Chapter 6).
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CHAPTER 4: MITOCHONDRIAL REMODELING FOLLOWING OGD/R: TIPPING THE
SCALES TO A FRAGMENTED MORPHOLOGY
1. Rationale
Mitochondria are highly dynamic organelles constantly undergoing fusion and
fission. These two events are essential to maintain mitochondrial homeostasis and cell
stability by providing an equilibrium of long interconnected networks as well as small
fragmented mitochondria [14, 15, 274]. In pathophysiologic states, such as I/R injury,
there is substantial evidence that excessive mitochondrial fragmentation is associated
with cell death [15, 240, 243, 274-279]. To date, studies focused on mitochondrial
fragmentation in the context of I/R injury have been limited by their classification of
mitochondrial morphology. Qualitative and semi-quantitative scoring methods lack
precision and accuracy of physiologically relevant mitochondrial morphologies and
investigator-associated bias in scoring may confound the results.
Accordingly, we developed a non-biased semi-automated machine learning-based
classification system to characterize mitochondrial morphology during OGD/R in primary
cortical neurons. We hypothesize that (i) utilizing a machine learning-based classification
can provide accurate quantification of mitochondrial dynamic states during, and ii)
mitochondria will undergo significant remodeling during OGD/R, resulting in extensive
fragmentation.
2. Experimental Design

Primary cortical neurons were isolated from mitoQC reporter mice (containing
fluorescent proteins fused to fis1 for mitochondrial localization) and plated onto glass
coverslips. After 14 days in vitro (DIV14), cells were subjected to 2.5h of OGD followed
by up to 6h of reoxygenation (6R). Coverslips were fixed with 3.7% PFA in 200 mM
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HEPES (Fig. 4-1) at the end of OGD within the hypoxic chamber (time = 0R), or at 1, 2,
4, and 6 hours after reoxygenation (1R, 2R, 4R, and 6R) Coverslips were imaged and
analyzed for mitochondrial morphology using the green (GFP) channel for quantification.

Fig. 4-1. Experimental schematic. Primary Cortical Neurons were isolated from mitoQC transgenic mice
from P0-P1. Experiments were conducted on DIV14. Cells were subjected to a 2.5h OGD, and a 6h
Reoxygenation period. Cells were fixed at 0R, 1R, 2R, 4R, 6R, and compared to control.

3. Results
3.1 Identification of Distinct Mitochondrial Morphologies
Analysis of primary cortical neurons from mitoQC transgenic mice with fluorescent
microscopy revealed four distinct mitochondrial morphologic groupings: network,
unbranched, swollen, and punctate (Fig 4-2A). To validate the independence of these
observed morphologies, mitochondrial objects (mitochondrial localized-GFP) were
segmented and measured using my newly developed semi-automated image processing
workflow detailed in Chapter 2. Comparison of morphologies across size and shape
descriptors identified distinct groupings of characteristics in these morphologic categories
(Fig 4-2B-C). The shape descriptors circularity (
and area equivalent diameter (2

√

^

), interfacial density (

),

) were significantly different among all groups.

Aspect ratio (AR) (the ratio of an object's width to its height,

), was also significantly

different between networks vs. swollen, networks vs. punctate, unbranched vs. swollen,
and unbranched vs. punctate. AR was not statistically different between networks vs.
unbranched as well as swollen vs. punctate categories. Next, a principal component
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analysis was applied to visualize group differences between mitochondrial objects (Fig 42D). A total of 32 measurements were collected for each object and z-scores were
calculated for each variable to compare differences across all morphologies. A summary
of the scaled measurements is shown across each morphology in Fig. 4-3. Variables were
grouped by similarity. Networks display high z-scores for variables that measure size
(such as area and perimeter) and, conversely, have low z-scores for variables that
measure spherical shape (such as circularity or roundness). The unbranched morphology
displays

high

z-

scores for variables
that measure length
(such

as

aspect

ratio

and

elongation),

while

also containing low
values for circularity
and

roundness.

Punctate

and

swollen
mitochondria
display

high

z-

scores for variables
that
spherical
specifically

measure
shape,

Fig 4-2: Identification of distinct mitochondrial morphologies. A) Four
distinct morphologies were identified in primary cortical neurons from mitoQC
transgenic mice: Network, unbranched, swollen, and punctate. B-C)
Mitochondrial morphologies differ significantly in circularity, aspect ratio,
interfacial density, and area equivalent diameter. D) PCA of mitochondrial
objects. Each point represents a single mitochondrial object, each color
represents a different morphology: network (blue), unbranched (purple), swollen
(green), and punctate (red). Difference across groups were computed using oneway ANOVA with Tukey post-hoc analysis. Multiple comparisons were pairwise.
****p<0.0001. Scale bar = 6 µm.
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circularity and roundness, and contain lower z-scores that measure size like area and
perimeter. Punctate and swollen mitochondria mainly differ in size, where swollen objects
have higher z-scores in area equivalent diameter, ferret, and hexagonal perimeter.
Importantly, interfacial density (Fig. 4-3: intfc_D.microns.1.) displays the greatest
difference between swollen and punctate morphologies.
3.2. Machine Learning Classification of Morphology: Model Performance
In order to develop the
model for the classification of
mitochondrial morphology, a total
of 2342 mitochondrial objects
were segmented from 4 different
images (2 from control conditions,
and

2

from

conditions),

fragmented

measured,

classified.

The

and

mitochondrial

objects were split on the basis of
their classification into a training
set (80%, 1874 objects) and a test
set (20%, 468 objects). A machine
learning model was developed
based upon the training set, and Fig. 4-3. Comparison of scaled measurements across
different morphologies. 32 different measurements were

later validated using the test set. collected for each mitochondrial object. Z-scores were
The

model

Random

was

Forest

built

calculated for each variable to compare differences across all
upon morphologies. Variables were grouped based on similarity. Red
color corresponds to a high z-score, while blue corresponds to
a low z-score.

classification
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methodology. In our model, a
mitochondrial object is sent
through a number of parallel
decision trees, in which each
tree provides an output or
vote. Each object is assigned
one of the four morphologies
at

the

conclusion

of

a

decision tree based on the
morphology with the majority
of votes. The final model
consisted of 500 trees with an
mtry = 2, which refers to the
number of randomly selected
predictors considered at each
split within the tree.
For validation of model
accuracy, the test set of
mitochondrial objects were
run

for

predicted

morphologies. Accuracy was

Fig. 4-4: Model performance. Model performance was analyzed
using the test set data (468 objects). A) Confusion matrix shows
that only two objects out of 468 were mislabeled. B) Overall
accuracy was 99.57% with a kappa of 99.39%. Sensitivity,
specificity, precision, and Balanced accuracy for all morphologies
were over 98.9%. C) Segmented and processed representative
images from control and fragmented conditions. D) Images applied
to classification system, green = network, blue = unbranched,
yellow = swollen, and red = punctate. Scale Bar = 10 µm.

determined using a confusion
matrix, which cross tabulates observed and predicted classes to observe error tendencies
of the model (Fig4-4A) [271]. The columns represent the referenced morphologies and
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rows represent the predicted morphologies. The confusion matrix revealed that out of the
468 objects within the test set, only two objects were mislabeled, a swollen mitochondria
for punctate and an unbranched mitochondria for swollen. The overall accuracy
(computed

as

the

proportion

of

total

correct

predictions,

) was calculated as 99.57% with a kappa (accuracy
accounting for chance agreement,
99.39%

(Fig.

Additionally,
presented

%

%
%

) of

4-4B).

the

model

highly

specific

and sensitive predictions for
each

morphology.

Sensitivity

(

specificity

(

above

and

99.41%

)

was

for

each

morphology. Precision, the
ratio

of

prediction

correct
to

positive

the

total

predicted positives (

),

was over 98.90% for all Fig 4-5: Total mitochondrial object count and area during OGD/R.
morphologies.
balanced

A) Representative images of mitoQC primary cortical neurons (green

Finally channel) subjected to OGD/R. B) Total mitochondrial object counts and

accuracy,

total mitochondrial area for each morphology across OGD/R. A chi-

the squared test was used to detect significant differences in object counts

and mitochondrial area. n = 6 biological replicates per time point, scale
average between sensitivity bar = 10 µm.
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and specific for each group (

) was over 99.32% for all morphologies.

Representative images as well as classified object masks (green = networks, blue =
unbranched, yellow = swollen, and red = punctate) are displayed by in Fig. 4-4C-D
respectively, as an example of our classification system.
3.3 Machine Learning Prediction of Morphology during OGD/R
Visually, primary neurons subjected to OGD/R have changes in mitochondrial
morphology (Fig. 4-5A). After applying our machine learning classification system, total
mitochondrial objects and area were tabulated for each morphology over control, 0R, 1R,
2R, 4R, and 6R timepoints (Fig. 4-5B). Chi-squared tests demonstrated significance in
both the number of mitochondrial objects and the area of mitochondrial objects.
To quantify differences between time points for each morphology, percent objects
and area were calculated (Fig. 4-6A). Significant differences were observed in percent
objects for each morphology (Fig. 4-6B). Percent networks were significantly decreased
at 0R (p<0.05) and 1R (p<0.01) before returning to control levels at 2R, 4R, and 6R.
Percent unbranched objects demonstrated a significant decrease at 0R (p<0.0001) and
persisting throughout reoxygenation (1R: p<0.0001, 2R: p<0.01, 4R: p<0.01, and 6R:
p>0.001) as compared to control. In contrast, percent swollen objects were significantly
increased at 0R (p<0.01), 1R (p<0.01), 2R (p<0.05), 4R (p<0.01), and 6R (p<0.01) as
compared to control and percent punctate objects were also significantly increased at 0R
(p<0.01) and 1R (p<0.01) when compared to control.
Changes in percent area were only observed for swollen and punctate
morphology in regard to percent area (Fig. 4-6C). Percent area of swollen mitochondria
was significantly increased at 1R vs. control (p<0.05). Additionally, percent area of total
punctate objects was significantly increased at 0R (p<0.05) and 1R (p<0.01) as compared
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with control. Percent are of networks and unbranched objects remain unchanged.

Fig 4-6: Comparisons of mitochondrial morphologies during OGD/R. A) Stacked bar graphs showing
percent mitochondrial objects and percent area over OGD/R. B) Individual comparisons of percent
mitochondrial objects for each morphology over OGD/R. C) Individual comparisons of percent mitochondrial
area for each morphology over OGD/R. Differences across time were computed using one-way ANOVA
with Dunnett post-hoc analysis. Multiple comparisons were assessed by comparing the means of each time
point with the mean of the control. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n = 6 biological replicates.

4. Summary
In summary, we report that by utilizing a semi-automated machine learning
program to classify mitochondrial morphology, the mitochondrial network undergoes
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extensive remodeling during OGD/R in primary cortical neurons. Specifically, there is a
loss of networks and unbranched mitochondria accompanied by an increase in swollen
and punctate mitochondria. While, significant differences in mitochondrial area were only
observed in swollen and punctate mitochondria.
Networked mitochondria are significantly decreased 0R and 1R from control and
appear to come back to control levels at 2R, while there were no differences in area of
mitochondrial networks throughout OGD/R. Networks most likely undergo a transition
from smaller networks to unbranched mitochondria at 0R and 1R, while larger networks
remain intact. This would account for the loss of network mitochondria, but no observable
changes in mitochondrial area. Networks in control conditions constitute roughly 55%65% of mitochondrial content, which is the majority of mitochondrial area. Unbranched
mitochondria decrease significantly over the entirety of OGD/R as compared to control,
while unbranched area was unchanged. These data suggest that unbranched
mitochondria divide and transition into punctate and swollen mitochondria. When
networks divide and mitochondria transition to the unbranched pool, we predict that the
smaller unbranched mitochondria are the first to fragment, while longer unbranched
mitochondria remain intact. Similar to networks, this could account for the lack of a
significant decrease in unbranched mitochondrial area.
Both punctate and swollen mitochondria numbers are significantly increased
following OGD and during reperfusion. Interestingly, punctate mitochondria increased at
0R and 1R before returning to control levels, while swollen mitochondria remained
increased across the entirety of OGD/R. This suggests a possible transition from punctate
mitochondria to swollen mitochondria. Previously, our lab reported that, during OGD,
extensive mitochondrial fragmentation occurs in a Drp1-dependent manner due to energy
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deprivation [240]. Upon reoxygenation, ROS production will damage mitochondria and
induce mitochondrial permeability transition pore (mPTP) opening, resulting in
mitochondrial swelling, the release of programmed cell death factors, and ultimately
induction and execution of cell death [13, 280]. Therefore, these data suggest that
punctate mitochondria returning back to control levels is potentially the transition of these
mitochondria from a punctate morphology to a swollen morphology upon induction of cell
death processes. Similarly, punctate area was significantly increased at 0R and 1R, while
swollen area was only increased at 1R. Both punctate and swollen mitochondria contain
relatively small areas, therefore the more objects that are present, the larger area those
objects will occupy. However, swollen mitochondria vary widely in size compared to
punctate mitochondria. This variability could explain why significant increases were only
observed at 1R, where it appeared the most extensive alterations of mitochondrial
architecture were taking place.
In conclusion: utilizing a highly accurate, non-biased, semi-automated machine

Fig. 4-7. Summary of mitochondrial morphologies changes during OGD/R. Data were calculated as
percent change from control for both mitochondrial objects and mitochondrial area. Data was analyzed
individually for each morphology using one-way ANOVA Dunnetts post-hoc analysis to detect differences
across time points versus control. *p<0.05, punctate; #p<0.05, swollen; $p<0.05, unbranched; †p<0.05,
networks. n = 6 biological replicates.
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learning-based classification system, we were able to characterize mitochondrial
dynamics with high resolution. These data support that mitochondria undergo extensive
fragmentation throughout OGD/R and provide a highly sensitive and specific tool that may
allow detailed analysis of the transition of morphologic states in multiple disease states.
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CHAPTER 5: MITOPHAGIC FLUX DURING ISCHEMIA/REPERFUSION
1. Rationale
Maintaining a healthy mitochondrial network is critical for cell survival.
Mitochondria must have active degradation of dysfunctional mitochondria through
mitophagy that is counterbalanced with biogenesis of mitochondrial lipids and proteins to
maintain a healthy mitochondrial network and meet the energetic needs of a cell.
Dysfunctional mitochondria produce ROS that can damage mitochondrial and cellular
components, and without recycling of mitochondrial components, the cumulative
consequences of excessive mitochondrial dysfunction can lead to release of
mitochondrial pro-death signals such as cytochrome C. Therefore, it is essential that
dysfunctional mitochondria be degraded through mitophagy. As reviewed in Chapter 1,
I/R injury induces the accumulation of dysfunctional mitochondria and there is evidence
to suggest that mitophagy is upregulated during this process. Mitophagy is a dynamic
process, making assessment complicated. Numerous studies have investigated
mitophagy through the conversion of LC3-I to LC3-II, colocalization of mitochondria and
lysosomes, expression levels of PINK1 and Parkin, and the loss of mitochondrial content.
LC3 conversion reveals changes in autophagosome initiation, and colocalization studies
provide poor resolution of protein or organelle interaction. Although LC3, PINK1, and
Parkin levels may increase, this cannot be interpreted as conclusive evidence of
increased mitophagy, and depending on the goal of the analysis, these data are unable
to identify protein molecules that have already been degraded by mitophagy.
Furthermore, while mitophagy may be inferred by measurement of mitochondrial content,
it fails to provide insight into the events leading to the actual clearance of mitochondria.
To address these issues, we performed OGD/R on primary cortical neurons
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isolated from the novel mitoQC reporter
mouse

(C57BL/6-

Gt(ROSA)26Sortm1(CAGmCherry/GFP)Ganl/J) (Fig. 5-1) [267].
The reporter allele contains a CAG promoter
and mCherry-GFP-mtFIS1 fusion protein
inserted into the Gt(ROSA)26Sor locus on
chromosome 6. During normal physiological
conditions, mitochondria are tagged with
both

mCherry

and

GFP

fluorophores,

providing an overlapping signal for both red
and green fluorophores on mitochondria.
When mitochondria are sequestered to the
lysosome, the acidic environment quenches
the GFP (pKa 5.9), while mCherry (pKa 4.5)
remains stable, resulting in a loss of the GFP
signal, while mCherry fluorescence remains
intact. This allows resolution of mitochondria
inside

auto/endo-lysosomes.

hypothesize

mitophagic

flux

We
will

be

Fig. 5-1. MitoQC reporter mice. MitoQC mice are
dual reporters containing both mCherry and GFP
fused to Fis1, an outer mitochondrial membrane
protein. The dual reporter contains a CAG promoter
and is inserted into the Gt(ROSA)26Sor locus on
chromosome 6. Mitochondria give off a yellow color
during
normal
physiological
conditions.
Dysfunctional mitochondria are targeted for
mitophagy, mitochondria are sequestered and
transported to the lysosome via the endosomal or
autophagosomal pathway. Lysosomal enzymes will
quench GFP (pKa 5.9), while mCherry (pKa 4.5)
remains stable, resulting in red fluorescence. Scale
bar = 10 µm.

significantly increased following OGD/R.

2. Experimental Design
Primary cortical neurons were isolated from mitoQC reporter and WT mice
between P0-P1. MitoQC neurons were plated on 12 mm glass coverslips at a density of
300K cells, while WT neurons were plated on 60 mm dishes at a density of 5 million cells.
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On DIV14 neural cultures were exposed to 2.5 hours of OGD and 6 hours of
reoxygenation (Fig. 5-2). Samples were taken at 6 different time points (control, 0R, 1R,
2R, 4R, and 6R) for both PFA fixation or fractionation. Coverslips were fixed with 3.7%
PFA in 200 mM HEPES, and 60 mm dishes were scraped down for homogenization and
mitochondrial fractionation. For the 0R timepoint, coverslips were fixed inside the hypoxic
chamber at the end of OGD, while 60 mm plates were taken out of the hypoxic chamber
and immediately processed for fractionation. Coverslips were imaged and analyzed for
the

presence

of

red

puncta

(mitophagy), while mitochondrial
fractions were probed for specific
protein markers associated with
mitophagy. (Chapter 2 - Methods)
3. Results

Fig. 5-2. Experimental design. Primary neurons were isolated
from both MitoQC mice and WT mice from P0-P1. On DIV14,
neural cultures were exposed to 2.5 hours of OGD and 6 hours
of Reoxygenation. Samples were collected at 6 separate time
points (control, 0R, 1R, 2R, 4R, and 6R). MitoQC cells were
fixed on glass coverslips, while WT cells were collected for
mitochondrial fractionation.

3.1. Mitophagy is Increased Following OGD/R
To evaluate mitophagic flux during the progression of ischemia/reperfusion, cells
exposed to OGD/R were analyzed for the status of mitophagic flux as indicated by
accumulation of mCherry fluorescence in the absence of mitochondrial GFP fluorescence
(mCherry puncta). Utilizing ImageJ, mCherry puncta were segmented and counted from
twelve images for each coverslip (Chapter 2 - Methods). Counts were normalized to cell
number to provide average mCherry object counts per cell. mCherry puncta were
significantly increased at 4R vs. control (p<0.05) (Fig. 5-3A). To validate mCherry as a
marker of mitochondria localized to lysosomes, mCherry puncta were analyzed in cells
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co-labeled with immunofluorescence for the lysosome marker LAMP1 and analyzed for
co-localization (Manders Correlation Coefficient) of LAMP1 and mCherry puncta (Fig. 53B). Colocalization was quantified to identify the extent of mCherry positive puncta

Fig. 5-3. Mitophagic flux is increased following OGD/R. A) Utilizing mitoQC reporter mice, cells were
analyzed for the presence of mCherry puncta. B) Cells containing mitoQC were stained with LAMP1, a
lysosomal marker, to determine mCherry puncta lysosome colocalization. Colocalization using Manders
Correlation Coefficient was used to determine how much mCherry was colocalizing with LAMP1 throughout
OGD/R. In addition, LAMP1 particle counts were analyzed and normalized to cell count. Differences across
time were computed using a one-way ANOVA with Tukey post-hoc analysis for multiple comparisons tests.
*p<0.05 vs controls, n = 6 biological replicates. Scale bar = 10 µm

containing LAMP1 positive puncta during the progression of ischemia/reperfusion injury
in cells exposed to OGD/R (Fig. 5-3B). The results show significant increases across all
time points of OGD/R when compared to control (0R: p<0.05, 1R: p<0.01, p<0.001, 4R:
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p<0.05, 6R: p<0.01). In addition, total LAMP1 puncta number per cell was significantly
increased at 4R vs. control (p<0.05), matching the increases in mCherry puncta. These
data support the validity of quantifying mCherry puncta as an index of mitochondria in
lysosomes and demonstrate a significant increase in mitophagic flux at 4 hours of
reoxygenation.
3.2 Mitophagy Via the PINK1/Parkin Pathway in Ischemia/Reperfusion Injury
As reviewed in Chapter 1, mitophagy occurs through multiple pathways. My
studies focus on mitophagic flux following OGD through the PINK1/Parkin pathway. This
pathway is the most well characterized mitophagy pathway, and has been implicated as
a major therapeutic target for various neurodegenerative diseases such as Alzheimer’s
and Parkinson’s Disease [281-285]. In addition, previous studies have suggested its
involvement in ischemia/reperfusion injury in both heart and brain [260, 286-288]. To
investigate the activation of this pathway, I evaluated the co-localization of PINK1 and
Parkin to mitochondria, as mitochondrial localization is considered a reliable marker for
mitophagy activation. WT cells were immunolabeled with PINK1 or Parkin and coimmunolabeled with the antibodies against the Beta subunit of ATP synthase (ATPB) as
a mitochondria marker (Fig. 5-4A and B). Colocalization of PINK1 or Parkin with ATPB
was analyzed with Pearson’s Correlation Coefficient (PCC) in ImageJ. PINK1
colocalization with mitochondria was significantly increased from control at 0R (p<0.05),
1R (p<0.01), and peaking at 2R (p<0.001) (Fig. 5-4C). Parkin colocalization was
significantly lower from control at 0R (p<0.001), while being significantly increased from
control at 1R (p<0.01), 2R (p<0.01), 4R (p<0.001), and 6R (p<0.0001) (Fig. 5-4C).
A complimentary methodology to evaluate mitochondrial localization of PINK1 and
Parkin was also used to verify activation of this mitophagy pathway. Western blot of
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data suggest that PINK1

peaks at 2R, just before our

1R
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p<0.05) (Fig. 5-4E). These

following reoxygenation and
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translocation occurs early

Mitochondrial Fraction
C

kD
250

1R
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Fig. 5-4. PINK1/Parkin mediated mitophagy. A) Cells labeled with
PINK1 and ATPB for colocalization of PINK1 and mitochondria. B)
Cells labeled with Parkin and ATPB for colocalization of Parkin and
mitochondria. C) Quantification of colocalization coefficient.
Compared with one-way ANOVA: Tukey post-hoc. PINK1: n = 4,
Parkin: n =3, *p<0.05. D) Western Blot of mitochondrial fractions for
PINK, Parkin, and ubiquitin. E) Quantification of protein levels,
normalized to VDAC. Differences were analyzed using one-way
ANOVA with Dunnett’s post-hoc analysis. Ubiquitin: n = 6, PINK1, n =
5, Parkin: n = 8, *p<0.05. Scale bar = 10 µm.
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through late reoxygenation, perhaps until dysfunctional mitochondria are cleared. This is
supported by evidence provided by Ordureau et al., that revealed a feedforward
mechanism for Parkin translocation and mitochondrial ubiquitination [149]. Accordingly,
as an additional indicator of Parkin activity, we analyzed mitochondrial fractions for
general protein ubiquitination (Fig. 5-4D). Mitochondrial protein ubiquitination is a direct
effect of Parkin activity on the mitochondria, tagging mitochondria to degradative systems
for removal [153, 289]. We observed a significant increase of mitochondrial ubiquitination
at 2R (p<0.05), corresponding to the timepoint where peak increases in PINK1 and Parkin
translocation were detected (Fig. 5-4E). These data suggest that following I/R injury,
PINK1/Parkin pathway is activated and mitophagy is induced.
3.3. Mitochondrial Clearance Through the Rab5 Endosomal Pathway
Our data show an increase in mitochondrial ubiquitination, activation of the
Pink/Parkin pathway of mitophagy, and accumulation of mitochondrial contents in
lysosomes. Mitochondria transport to the lysosome for degradation can occur through two
distinct pathways, the autophagosomal and the endosomal pathways. We evaluated the
induction of both pathways to gain insight into how mitochondrial clearance may occur
following an ischemic insult in neurons. To evaluate the autophagosomal pathway, we
probed for LC3 conversion via proteolytic activation from LC3-I to LC3-II (an indicator of
autophagy activation). To evaluate the endosomal pathway, we assayed the expression
level of Rab5 (endosomal marker), and its presence in mitochondrial fractions as an
indicator of mitochondrial sequestration in endosomes (Fig. 5-5A). Whole cell lysates
revealed no significant changes in LC3 conversion, but a significant increase of Rab5
expression at 4R (p<0.01) when compared to control (Fig. 5-5B). Similarly, mitochondrial
fractions revealed no significant changes in LC3 conversion, but demonstrated significant

67
increases from control in
Rab5 expression at both
2R

(p<0.01)

(p<0.05).

and

These

4R
data

suggest

that

mitochondria

are

sequestered

in

Rab5

endosomes for transport
to lysosomes, and not
through

autophagic
Fig. 5-5. Mitochondria are degraded by the Rab5 endosomal pathway.

pathways involving LC3 A) Western Blot of LC3 (autophagy marker) and Rab5 (endosome marker)
conversion.

in whole cell lysates and mitochondrial fractions. B) Quantification of LC3
conversion and Rab5 expression in whole cell lysates, normalized to
GAPDH, LC3: n = 6, Rab5: n = 7, C) Quantification of LC3 conversion and
Rab5 expression in mitochondrial fractions, samples normalized to VDAC,
LC3: n = 4, Rab5: n = 4. Differences between groups were computed by
one-way ANOVA with Dunnett’s post-hoc analysis for multiple comparisons
tests. Means of each time point were compared to the mean of the control.
*p<0.05

3.4 Mitochondrial Morphology Classification of mCherry Puncta
In Chapter 4, my mitochondrial morphology classification system revealed
significant alterations to mitochondrial architecture during OGD/R. Specifically there was
a significant increase in punctate morphology during OGD and early reoxygenation, which
reverted to control levels at 2R. Additionally, there were significant increases in swollen
mitochondria during OGD that persisted throughout the entirety of reoxygenation. To
determine if a specific morphology is most likely to be sequestered for mitophagic
degradation, I employed our classification system to identify mCherry puncta morphology.
Segmented mCherry puncta masks were generated and analyzed using our classification
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system (Fig. 5-6A). Total mCherry puncta objects were counted for 4 biological replicates
and groups compared for statistically significant differences using a Chi-squared test (Fig.
5-6B). Punctate morphology represented the majority of mCherry puncta with a total count
of 38,449 objects throughout OGD/R, consisting of 85.9% of red puncta (Fig. 5-6B, C).
Interestingly, the number of unbranched objects totaled to 3,727, representing 8.5% of
mCherry puncta. Swollen mitochondria contained the third highest number of objects
totaling to 2,848, which represented 5.58% of red puncta. Networks contained the lowest
number of objects at 12, representing 0.02% of red puncta. objects. mCherry puncta
puncta were compared to classified mitochondrial objects measured in Chapter 4 to
compare sizes (Fig. 5-6D). For all classifications, mCherry puncta demonstrated lower
average area when compare to mitochondrial classified objects. mCherry puncta

Fig. 5-6. Mitochondria morphology classification of mCherry puncta. A) mCherry puncta were
segmented from images of mitoQC neurons and analyzed using our mitochondrial morphology
classification system. B) Total mCherry puncta counts over OGD/R. C) Stacked bar graphs representing
percent red puncta over OGD/R. D) Violin plots displaying relative distributions of area for mCherry puncta
(mCherry only) and mitochondrial (GFP-Fis1). mCherry puncta: n = 4 biological replicates, 44,536 objects.
Mitochondria: n = 1 biological replicate, 43,434 objects. Scale bar = 10 µm.
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networks had an average area of 8.822  2.252 m2 as compared to mitochondrial
networks (25.467  56.991 m2). Unbranched mCherry puncta had an average size of
1.440  0.981 m2 as compared to unbranched mitochondria (2.871  1.812 m2).
Swollen mCherry puncta had an average area of 1.681  0.649 m2 as compared to
swollen mitochondria (2.126  1.066 m2). mCherry puncta that were classified as
punctate had an average size of 0.382  0.233 m2 as compared to punctate mitochondria
(0.582  0.215 m2). These data suggest that punctate mitochondria are most likely
tagged for degradation. In addition, macro-mitophagy may occur on unbranched or
network objects, but objects are smaller than 10 µm2.
4. Summary
In summary, we report that mitophagic flux is significantly increased following
OGD/R, indicated by the increased presence of mCherry puncta within neurons extracted
from mitoQC reporter mice. This is accompanied by increases in the number of
lysosomes present during reoxygenation and significant increases in colocalization of
mCherry puncta with Lamp1-positive lysosomes. Increases in mitophagic flux correspond
to the activation of the PINK1/Parkin pathway of mitophagy during ischemia/reperfusion.
This was demonstrated by an increase in both PINK1 and Parkin in mitochondrial
fractions as well as increased colocalization of PINK1 and Parkin with the mitochondrial
marker ATP synthase (ATPB). In further support of mitophagy induction, the primary
target of Parkin activity, mitochondrial ubiquitination, was significantly increased following
OGD/R. In our model of OGD/R of primary cortical neurons, autophagic sequestration
through LC3 containing autophagosomes does not appear to be activated. However, the
increase in Rab5 in mitochondrial fractions is indicative of activation of the endosomal
pathway. Therefore, mitochondrial degradation is likely carried out through the endosomal
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pathway in the setting of ischemia/reperfusion injury. Lastly, our mitochondrial
morphology classification system revealed that the predominate state of mitochondria
undergoing mitophagy is a punctate morphology.
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CHAPTER 6: THE ROLE OF DRP1 IN MITOCHONDRIAL DYNAMICS AND QUALITY
CONTROL
1. Rationale
Mitophagy and mitochondrial dynamics have been well studied separately in
response to I/R injury, but investigations aimed at elucidating the interplay between these
two components of mitochondrial quality control are limited. Overwhelming evidence
suggests that excessive mitochondrial fission is directly linked to cell death while, in
contrast, mitochondrial fusion is protective [231, 233, 241, 242, 260, 279, 290-294]. Yet,
these studies fail to explain: i) why fusion might be protective, ii) why fission is causally
linked to cell death, iii) why pharmacologic inhibition of fission is only protective when
initiated prior to ischemia [242, 279], but, paradoxically, is detrimental when initiated
during reperfusion [259], and finally, iv) whether fission is necessary to dispose of
damaged mitochondria through mitophagy following I/R injury. Previous studies suggest
a complex relationship between mitochondrial dynamics and mitophagy where fission
inhibition during ischemia may provide improved outcomes [243, 260, 279], but this same
inhibition of mitochondrial fragmentation may prevent the mitophagy recovery pathway
during reperfusion that is needed to remove damaged mitochondria.
Drp1 is a key regulator of mitochondrial fission and has also been implicated as a
key component of the mitophagic process allowing damaged portions of the mitochondrial
network to be fragmented and sequestered for recycling through mitophagy/biogenesis
[196, 198, 199, 236]. Overexpression of Drp1 in HeLa cells resulted in a 70% decrease
in mitochondrial mass and endophilin B1, a Drp-1 dependent mediator of fission, was
found to colocalize with autophagic markers LC3, Atg5, and Atg9 in response to nutrient
starvation [196, 198, 199]. In addition, there is evidence to suggest that overexpression
of Parkin in mouse N2a neuroblastoma cells may protect against OGD/R through
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ubiquitination and proteasomal degradation of Drp1 [236]. Despite these associations,
the role of Drp1 in mitophagy and ultimately maintaining cell viability in response to I/R
injury remains unclear.
We hypothesized that inhibition of Drp1 would prevent disruption of the
mitochondrial network and lead to reduced mitophagy. To gain further insight into these
mechanisms of mitochondrial dysfunction, we crossed mitoQC reporter mice with Drp1fl/fl
mice provided from Dr. Hiromi Sesaki. Drp1fl/fl mice contain loxP sites inserted next to
exons 3 and 5, located in an essential GTPase domain [268]. Cortical neurons were
isolated from mitoQCki/+/Drp1fl/fl mice and subjected to OGD/R to determine how Drp1
knockout affects mitochondrial dynamics, mitophagic flux, and cell viability.
2. Experimental Design
Primary cortical neurons were isolated from QCki/+/Drp1fl/fl and Drp1fl/fl mice
between P0-P1. QCki/+/Drp1fl/fl neurons were plated onto 12 mm glass coverslips for PFA
fixation, while Drp1fl/fl neurons were plated onto 60 mm dishes and 24-well plates for
fractionation and viability assays.
Neurons were infected with either
LV-EF1a-empty or LV-EF1a-Cre
on DIV7 and experiments were
conducted on DIV14 (Fig. 6-1).
QCki/+/Drp1fl/fl

neuron

cultures

were exposed to 2.5 hours of OGD
then fixed with 3.7% PFA in 200
mM HEPES at 6 different time
points (control, 0R, 1R, 2R, 4R,

Fig. 6-1. Experimental design. A) Lentiviral toxicity was
evaluated over 5 different concentrations of LV-EF1a-empty.
Data was assessed by MTT, n = 4. B) Representative images
of neuron viral transduction efficiency post-transduction day 7.
Neuron cultures were treated with 0.5X and 1X (shown) LVEF1a-GFP and co-labeled with immunofluorescence for the
neuron marker MAP2. C) Quantification of infection rate was
calculated by the number of MAP2+ cells containing GFP
divided by the total number of MAP2+ cells, n = 3. D) Western
Blot and quantification of Drp1KO after transduction with 0.5X,
1X, and 2X LV-EF1a-cre in Drp1fl/fl primary neurons, n = 3.
Scale bar = 20 µm
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6R) and analyzed for mitochondrial morphology and mitophagic flux. Drp1fl/fl neurons
were analyzed by western blot for protein markers associated with mitophagy at three
time points (control, 2R, 4R). In addition, Drp1fl/fl neurons were assessed for cell viability
at 6R by MTT assay.
3. Results
3.1 Lentiviral Transduction of Primary Cortical Neurons
To optimize target gene knockout with lentiviral-Cre delivery in primary cortical
neurons we first conducted preliminary experiments to evaluate (i) cell viability, (ii)
infection rate, and (iii) loss of protein target. Viral toxicity was determined with five
escalating concentrations of lentivirus (LV-EF1a-empty-VSVG; concentrations 0.5X, 1X,
2X, 4X, 5X) and viability was
assessed

7

days

post-

transduction by MTT assay.
All

concentrations

significant

had

decreases

in

viability, resulting in a ~25%
reduction

of

viability

at

concentrations of 2X and
above

(Fig.

validate

neuron

transduction
cortical

6-2A).

To
viral

efficiency,

neurons

were

transduced with 0.5X and 1X
LV-EF1a-GFP-VSVG

and

Fig. 6-2. Lentiviral transduction of primary cortical neurons. A)
Lentiviral toxicity was evaluated over 5 different concentrations of LVEF1a-empty. Data was assessed by MTT, n = 4. B) Representative
images of neuron viral transduction efficiency post-transduction day 7.
Neuron cultures were treated with 0.5X and 1X (shown) LV-EF1a-GFP
and co-labeled with immunofluorescence for the neuron marker
MAP2. C) Quantification of infection rate was calculated by the number
of MAP2+ cells containing GFP divided by the total number of MAP2+
cells, n = 3. D) Western Blot and quantification of Drp1 knockout after
transduction with 0.5X, 1X, and 2X LV-EF1a-cre in Drp1fl/fl primary
cortical neurons, n = 3. Scale bar = 20 µm
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co-labeled with immunofluorescence for the neuron marker microtubule-associated
protein 2 (MAP2) on post-transduction day 3, 5, and 7 (Fig. 6-2B). Infection rate was
calculated as the number of MAP2+ neurons containing GFP fluorescence divided by the
total number of MAP2+ neurons. By 7 days of post-transduction the infection rate for both
0.5X and 1X LV-EF1a-GFP-VSVG was above 95% (Fig. 6-2C). It was assumed that all
concentrations above 1X, would yield similar results to 1X concentration in transduction
efficiency. Knockout of Drp1 (Drp1KO) was evaluated by transducing Drp1fl/fl neuron
cultures with 0.5X, 1X, and 2X LV-EF1a-cre-VSVG concentrations and blotting for the
presence of Drp1 in whole cell lysates (Fig. 6-2D). Quantification of the blots revealed a
75% knockout of Drp1 protein in Drp1fl/fl neuron cultures with lentiviral-cre delivery (Fig.
6-2D). Based on these data, 2X lentivirus concentration with a 7-day transduction period
yielded the optimal knockout of Drp1.
3.2 Drp1KO Stabilizes Mitochondrial Morphology during OGD/R
To evaluate how Drp1KO affects mitochondrial morphology following OGD/R,
QCki/+/Drp1fl/fl cells infected with LV-EF1a-cre and exposed to OGD/R were analyzed
utilizing my mitochondrial morphology classification system (Chapter 4 – Mitochondrial
Remodeling Following OGD/R: Tipping the Scales to a Fragmented Morphology).
Microscopy of mitochondrial morphology demonstrated that, in control neurons exposed
to OGD/R, there was an apparent transition from large interconnected mitochondrial
objects to small mitochondrial objects. Drp1KO prevented this transition to small
mitochondrial objects at all timepoints (Fig. 6-3A). To analyze this morphologic disruption,
we applied our machine learning classification system to provide detailed analysis of this
morphologic disruption by comparing the number of mitochondrial objects and the area
of mitochondria in each morphologic state between conditions (LV-EF1a-empty vs. LV-
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EF1a-cre) and across OGD/R timepoints using two-way ANOVA followed by post hoc
analysis with Dunnett’s test (Fig. 6-3 B-C).
Classification of the number of networked mitochondrial objects revealed a
significant reduction in response to OGD/R (p<0.01), with only weak evidence of a
difference between control and Drp1KO groups (p = 0.052). In agreement with the total
object counts, the area of mitochondrial networks as a percent of total mitochondrial mass
was significantly reduced at early reoxygenation timepoints (0R and 2R; p<0.01) and this
reduction in mitochondrial network area was inhibited with Drp1KO compared to control
(Fig. 6-3B; Control vs. 0R:p<0.0001, 1R:p>0.05, 4R:p<0.001, and 6R:p<0.05). These
data demonstrate that Drp1KO attenuates fragmentation of larger mitochondrial networks
during OGD/R.
Consistent with induction of mitochondrial fragmentation, control neurons showed
a significant decrease in the total number of unbranched mitochondrial objects at all
timepoints post-reoxygenation (control vs. 0R:p<0.0001, 1R:p<0.01, 2R:p<0.01,
4R:p<0.01, 6R:p<0.05), however this decrease in number did not reflect a reduction in
the total area of mitochondria in the unbranched state (Fig. 6-3B). This suggests that
mitochondria in the unbranched state remain a stable percentage of the total
mitochondrial pool during OGD/R but increase in length to account for the decreased total
object number. The reduction of unbranched mitochondrial objects during ODG/R is
inhibited with Drp1 KO (Control vs. Drp1KO), demonstrating that this transition requires
Drp1 dependent fragmentation.

Interestingly, the total area of mitochondria in the

unbranched state is reduced overall with Drp1KO, but there is no effect of Drp1KO on the
unbranched mitochondrial object number. This suggests that Drp1 is essential to
maintaining unbranched mitochondrial size, and disruption of this pathway results in a
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shift toward fewer, longer unbranched mitochondria without disrupting the number of
mitochondria in this state under normal conditions (Fig. 6-3B-C).
Swollen mitochondria are characterized by their small size characteristics similar
in many ways morphologically to punctate mitochondria, with the primary morphologic
difference being the lower interfacial density, as described in Chapter 4. Swelling of
mitochondria is a welldocumented precursor to
induction of cell death
during
ischemia/reperfusion
injury. The total number of
mitochondrial objects and
the corresponding area of
mitochondrial content in a
swollen morphology were
significantly
response

altered
to

in

OGD/R

(p<0.01) and this effect Fig. 6-3. Drp1 KO stabilizes mitochondrial morphology during
was

ameliorated

Drp1KO
number

(p<0.01).
of

with
The

swollen

mitochondrial objects was
significantly increased in
control cells in response to

OGD/R. A) Representative images of QCKi/+/Drp1fl/fl primary cortical
neurons (GFP channel), infected with either LV-EF1a-empty or LVEF1a-cre, and subjected to OGD/R. B) Individual comparisons of percent
mitochondrial objects for each morphology over OGD/R. C) Individual
comparisons of percent mitochondrial area for each morphology over
OGD/R. Two-way ANOVA was computed to detect differences across
time and between conditions. Multiple comparisons across time were
assessed by comparing the means of each time point with the mean of
the control and were computed using Dunnett’s post-hoc analysis.
Multiple comparisons between conditions were computed using Sidak
post-hoc analysis. *p<0.05 across time, #p<0.05 between condition, n =
8 biological replicates per group, scale bar = 10 µm.

77
OGD/R (0R: p<0.05, 1R: p<0.01, 2R:p<0.01, 4R:p<0.05), while Drp1KO blocked this
increase in mitochondrial swelling (Fig. 6-3B). Similar effects were observed in percent
area of swollen mitochondria following OGD/R (p<0.001) and between groups (p<0.001).
Percent area of swollen mitochondria was significantly increased in control cells
throughout OGD/R (Fig. 6-3C: 0R:p<0.01, 1R:p<0.05, 2R:p<0.01, 4R:p<0.05), while
Drp1KO prevented any changes in mitochondrial swelling as a proportion of total
mitochondrial area (Fig. 6-3C: 0R:p<0.01, 1R:p<0.05, 2R:p<0.05, and 4R:p<0.01). These
data suggest that Drp1KO inhibits mitochondrial swelling induced by OGD/R.
Punctate mitochondria are characterized by their small size with no evidence of
swelling, thus a higher interfacial density. The number of mitochondrial objects in a
punctate morphology was not changed in response to OGD/R (p=0.086) or between
control and Drp1KO (p=0.355) (Fig. 6-3B). In contrast, the total area of mitochondrial
content in a punctate morphology demonstrated significant increases in response to
OGD/R (p<0.01) and between groups (p<0.001). Punctate area was significantly
increased throughout OGD/R (Fig. 6-3C: 0R:p<0.001, 1R:p<0.05, 2R:p<0.01, 4R:
p<0.05) and this increase was blocked with Drp1KO (Fig. 6-3C: 0R:p<0.001, 4R:p<0.001,
and 6R:p<0.05). A significant decrease in punctate area in Drp1 KO cells was also
observed at 4 hours of reoxygenation (Fig. 6-3B: 4R:p<0.05). These results suggest that
OGD/R does not cause an increase in the number of mitochondria in a punctate
morphology, but the total area of mitochondria in this state is increased, suggesting
punctate mitochondria are larger following ODG/R. Importantly, Drp1KO blocked the
increase in punctate area, most likely by preventing mitochondria fragmentation. When
considered with the increase in swollen mitochondria, these data suggest mitochondrial
fragmentation via Drp1 activity during OGD/R results in a rapid transition to a small
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swollen phenotype, consistent with induction of cell death.
3.3 Mitophagic Flux is Independent of Drp1
To evaluate the effect of
Drp1KO on mitophagic flux in the
progression ischemia/reperfusion
injury, QCki/+/Drp1fl/fl cells infected
with LV-EF1a-cre or LV-empty and
exposed to OGD/R were analyzed
for the accumulation of mCherry
puncta

as

an

indicator

of

mitophagic flux (as described in
Chapter 5- Mitophagic Flux during
Ischemia/Reperfusion). There was
a significant increase in mitophagic
flux

in

response

(p<0.0001),

but

to

no

OGD/R
effect

Drp1KO

(p=0.147).

puncta

accumulation

significantly

increased

of

mCherry
independent of Drp1. A)
was Fig. 6-4. Mitophagic flux is Ki/+
fl/fl

at

2R

(p<0.01), 4R (p<0.05), and 6R
(p<0.05) (Fig. 6-4B). Drp1 KO cells
demonstrated

a

significant

increase of mCherry puncta at 2R
(p<0.05), while 4R (p=0.069) and

Representative images of QC /Drp1
primary cortical
neurons, infected with either LV-EF1a-empty or LV-EF1a-cre,
subjected to OGD/R and analyzed for the presence of mCherry
puncta. B) Quantification of mCherry puncta per cell as well as
total LAMP1 puncta per cell during OGD/R. Two-way ANOVA
was computed to detect differences across time and between
conditions. Multiple comparisons across time were assessed
by comparing the means of each time point with the mean of
the control and were computed using Dunnett’s post-hoc
analysis. Multiple comparisons between conditions were
computed using Sidak post-hoc analysis. *p<0.05 across time,
#p<0.05 between condition, n = 8 biological replicates per
group, scale bar = 10 µm.
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6R (p=0.064) was not significant (Fig. 6-4B). Similarly, total LAMP1 particle counts
detected significant changes in response to OGD/R (p<0.01), but again no effect of
Drp1KO. Total LAMP1 particles were significantly increased at 6R (p<0.05) in control cells
(Fig. 6-4B). These data suggest that induction of mitophagic flux following OGD/R is
independent of Drp1.
3.5 Drp1-Independent Mitophagy is not Cleared Through the Rab5 Endosomal
Pathway
Our data show that ODG/R induces increased mitophagy and activation of the
PINK1/Parkin pathway. Our data also suggests that mitochondria were not degraded
through the LC-3 mediated autophagy pathway, rather through the Rab5 endosomal
pathway (Chapter 5). To evaluate how Drp1KO affects mitophagy during OGD/R, western
blot of mitochondrial fractions was performed on Drp1fl/fl cells exposed to OGD/R with and
without viral delivery of Cre expression. No significant changes were detected in PINK1
and Parkin translocation, or in general mitochondrial protein ubiquitination (Fig. 6-5C).
Interestingly, Rab5 expression in mitochondrial fractions revealed significant increase in
response to OGD/R (p<0.05) and a significant reduction in response to Drp1KO (p<0.01).
Mitochondrial Rab5 expression was significantly increased in control cells at 2R (p<0.01)
and was significantly higher than mitochondrial Rab5 expression observed in Drp1 KO at
2R (p<0.01) (Fig. 6-5C). Mitochondrial Rab5 expression was unchanged in Drp1 KO cells
during OGD/R. These data suggest that mitochondria in the absence of Drp1 is not
sequestered in Rab5 endosomes for transport to lysosomes.
Lastly, to investigate what effect Drp1 has on viability, Drp1fl/fl neurons infected
with LV-EF1a-cre were exposed to 2.5 hours of OGD and 6 hours of reoxygenation.
Viability was determined through MTT assay and was compared to Drp1fl/fl neurons
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infected with LV-EF1a-empty. Drp1 KO resulted in a 20% improvement in viability (Fig. 66) suggesting that Drp1 contributes to the progression of cell death during
ischemia/reperfusion.

Fig. 6-5. Drp1-Independent mitophagy is not cleared through the Rab5 endosomal pathway. A) Western
Blot of Drp1 KO in whole cell lysates during OGD/R. B) Western Blot of mitochondrial fractions probing for
PINK1, Parkin, Ubiquitin, and Rab5. C) Quantification of protein levels across OGD/R, normalized to VDAC.
Two-way ANOVA was used to detect differences across time and between conditions. Multiple comparisons
across time were assessed by comparing the means of each time point with the mean of the control using
Dunnett’s post-hoc analysis. Multiple comparisons between conditions were compareds using Sidak post-hoc
analysis. *p<0.05 across time, #p<0.05 between condition, n = 4 per group.
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Fig. 6-6. Drp1 KO improves cell viability. Drp1fl/fl cells were infected
with either LV-EF1a-empty for control or LV-EF1a-cre for Drp1 KO
and exposed to 2.5 hours of OGD followed by a 6-hour
reoxygenation. Viability was measured by MTT assay. Student’s Ttest was used to detect differences between the two groups. *p<0.05,
n = 10.

4. Summary
In summary, we report that Drp1 stabilizes mitochondrial architecture during
OGD/R. This was demonstrated by both mitochondrial number and percent area in
Drp1KO cells being unaffected by OGD/R. This is in direct contrast to control cells which
demonstrated extensive disruption to mitochondrial morphology with reduced
mitochondria in long networks or long unbranched morphologies and increased swollen
and punctate mitochondria. The increase in mitophagic flux was unaffected by Drp1KO,
as indicated by significant increases in mCherry puncta during OGD/R with Drp1KO. My
results suggest that mitophagy is likely mediated through the PINK1/Parkin pathway of
mitophagy and that mitochondria are sequestered by Rab5 endosomes for transport to
lysosomes. Although no significant differences were observed in PINK1 and Parkin
translocation to mitochondria, mitochondrial Rab5 expression was significantly repressed
in the absence of Drp1, suggesting that Drp1-independent mitophagy may not be through
the Rab5 endosomal pathway. These data in total suggest that improvements in cell
viability found with Drp1KO is likely mediated by limiting disruption of the mitochondrial
network rather than an effect of Drp1 inhibition on mitophagy.
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CHAPTER 7: DISCUSSION
1. Summary of Results
The present study tested 4 hypotheses to investigate the role of mitochondrial
quality control utilizing an in vitro model of ischemia/reperfusion. We made four novel
observations:
i)

Mitochondria morphology in primary cortical neurons can be classified into
4 distinct groups utilizing a machine-learning based classification system.

ii)

Mitochondria undergo significant remodeling during OGD/R, resulting in
extensive fragmentation and swelling.

iii)

Mitophagic Flux is significantly increased via the PINK1/Parkin Pathway of
Mitophagy and are sequestered by Rab5 endosomes for transport to the
lysosome. Furthermore, mitochondria inside lysosomes are primarily
punctate mitochondria.

iv)

Knockout of Drp1 stabilizes mitochondrial architecture, but has no effect on
mitophagic flux during OGD/R.

2. Classification of Mitochondrial Morphology: Current Knowledge and New
Contributions
Mitochondria are highly dynamic organelles, constantly undergoing cycles of
fission and fusion, generating an equilibrium of long interconnected and small punctate
mitochondria at homeostasis. As reviewed by Kulek et al., deviations in this equilibrium
have been observed in cell cycle progression and cellular differentiation, oxidative stress,
metabolic perturbation, and induction of programmed cell death pathways [274], thereby
generating considerable interest in this phenomenon. Despite the effort to study
mitochondrial dynamics, investigations have been limited by their measures of
mitochondrial morphology. Most studies utilized a qualitative or semi-quantitative
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approach by developing a scoring system of fission/fusion profiles [240, 275-278, 294,
295], which lack precision and accuracy of physiologically relevant mitochondrial
morphologies. To overcome this, recent studies have shifted to utilizing computational
image analysis, commonly referred to as Image Cytometry, which limit observer and
selection bias in morphological evaluations and demonstrate high throughput [296-301].
Similar to Leonard et al., our method aimed to measure four distinct morphological
phenotypes including the quantification of swollen mitochondria [301], but in mouse
primary cortical neurons.
2.1 Identifying Distinct Mitochondrial Morphologies
In Chapter 4, I extensively characterized 4 different mitochondrial morphologies
(network, unbranched, swollen, and punctate) and constructed a random forest classifier
to predict mitochondrial morphology in primary cortical neurons. The independence of
these observed morphologies displayed significant differences in 32 size and shape
descriptors. PCA analysis further confirmed 4 distinct groupings and tabulated z-scores
revealed how morphologies compared with respect to each descriptor. The differences
detected provided confidence of the feasibility of using this approach to classify
mitochondrial morphology utilizing machine learning algorithm.
2.2 Model Assessment
Model assessment revealed that mitochondrial morphology prediction was highly
specific. The model demonstrated an overall accuracy of 99.57% with a Kappa of 99.39%.
Model accuracy was calculated as the proportion of total correct predictions and out of
468 objects within the test set, only two objects were mislabeled. Those mislabeled
objects corresponded to confusion amongst swollen and punctate, as well as unbranched
and swollen. Swollen and punctate generally have similar shape descriptors, with primary
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morphological differences in size and interfacial density. Swollen objects are larger in size
and possess a lower interfacial density when compared to punctate objects. Our data
suggest that punctate mitochondria likely increase in size and transition to a swollen
phenotype under pathological conditions, therefore it is not surprising that swollen and
punctate mitochondria may be confused with one another, although this confusion is rare.
Unbranched mitochondria are distinguished primarily by shape, specifically aspect ratio
(AR) (the ratio of an objects width to its height). Long, skinny mitochondrial objects display
large values for AR as compared to small circular mitochondria. Because swollen and
unbranched mitochondria can have similar area, small unbranched mitochondria can be
classified as swollen mitochondria, but again are rare in occurrence.
The high overall accuracy in our model assessment could be influenced by
selecting images from two polarizing environments: highly fused and highly fragmented.
Additionally, images analyzed in our model are compressed z-stacks, therefore losing 3D resolution and potentially confounding results. Despite these concerns, in a relatively
flat monolayer of neurons along with high technical replication and classification of
hundreds of thousands of mitochondrial objects in a single experiment we report that
these mitochondrial morphologies can be accurately predicted using machine learning
techniques.
3. Mitochondria Fragmentation
Knowledge and New Contributions

Following

Ischemia/Reperfusion:

Current

There is a clear consensus that ischemia/reperfusion is associated with
mitochondrial fragmentation and subsequent cell death [240, 302-307]. Recent data
published in our lab demonstrate the complex temporal profile of mitochondrial fission
during OGD and reoxygenation in the HT22 neural cell line revealing a biphasic response,
with an initial but reversible phase of fragmentation observed during OGD, followed by a
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second and sustained period of fission [240]. These data highlight the complexity of this
phenomenon in the progression of ischemia/reperfusion and importantly, the need for
precise and biologically meaningful measurement of mitochondrial morphology and its
association with cell death. To address this, I utilized my classification system to measure
changes in mitochondrial architecture during OGD and reoxygenation in primary neurons.
3.1 Comparing Mitochondrial Morphologies during OGD/R
As expected, significant changes were observed in all mitochondrial morphologies
during OGD and reoxygenation (Ch. 4 – Mitochondrial Remodeling Following OGD/R:
Tipping the Scales to a Fragmented Phenotype). The number of mitochondria in a
network morphology was significantly decreased during OGD and early reoxygenation
before being restored to control levels, although no changes were observed in total area
occupied by mitochondrial networks. Networks make up over 60% of total mitochondrial
content, suggesting that some mitochondrial networks likely fragment, while remaining
networks expand in area and become larger and compensate for a loss in networked
mitochondrial number. The number of unbranched mitochondria decreased at all time
points throughout OGD and reoxygenation, while the total area of mitochondria in this
morphology remained constant. These data suggest that unbranched mitochondria may
be a transition point between networks and punctate mitochondria, with networks feeding
large unbranched objects into the unbranched pool, while smaller unbranched
mitochondria fragment into punctate and/or swollen mitochondria.
The decreases observed in networks and unbranched mitochondria were
accompanied by increases in punctate and swollen mitochondria. Punctate objects were
increased during OGD and early reoxygenation with corresponding increases in punctate
area, before restoring back to control. Swollen objects were increased throughout the
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duration of OGD/R with increases in swollen area at 1R. Swollen and punctate
mitochondria only make up 5% of mitochondrial content at control conditions and vary in
size, therefore a larger study may find significant differences at additional timepoints. The
restoration of punctate mitochondria to control levels at 2R could be due to a transition
from punctate to swollen mitochondria. Under periods of ischemia, ATP depletion induces
dis-equilibration of Ca2+ across the plasma membrane, resulting in high cytosolic Ca2+
and subsequent increases in intramitochondrial Ca2+ causing mitochondrial swelling
[308]. Upon reperfusion, excessive ROS production damages mitochondrial lipids and
proteins, this damage, in addition to Ca2+ dis-equilibrium, are major forces that induce
pathologic activation of the mitochondrial permeability transition pore (mPTP) [280].
Permeability transition of mitochondria causes mitochondrial swelling and, eventually
release of programmed cell death factors, and ultimately cell death [13, 280, 309].
Our analysis of mitochondrial morphology was performed over discrete time points,
lacking precise temporal resolution. Monitoring mitochondrial morphology in a single cell
over the duration of OGD/R would provide valuable information on the events leading up
to the different morphology profiles observed in our study. Nonetheless, our highly
sensitive and specific classification system has allowed the detailed analysis of the
transition of morphologic states in the progression of OGD and reoxygenation.
4. Mitophagic Flux in Ischemia/Reperfusion: Current Knowledge and New
Contributions
As discussed in Chapter 1 there is evidence to suggest that mitophagy is
upregulated in the ischemia/reperfusion injury. ROS production following reperfusion
induces extensive mitochondrial damage and dysfunction, threatening cellular health
through the release of pro-apoptotic factors. Therefore, it is critical to sequester and
degrade dysfunctional mitochondria through mitophagy. To date, studies have been
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limited in their measurement of mitophagy, resorting to methods of protein localization,
mitochondrial content, and qualitative measurements of images of mitochondria colocalized to lysosomes. Protein localization and expression do not provide conclusive
evidence of increased mitophagy and although visualizing mitochondria being engulfed
by autophagosomes/lysosomes confirms that mitochondria’s fate for degradation, it lacks
quantitative resolution to understand what is occurring in a population of cells in diverse
conditions. Therefore, we aimed to quantify mitophagic flux utilizing the mitoQC reporter
mouse, which allowed us to visualize and quantify mitochondria inside auto/endolysosomes during OGD/R.
4.1 Mitophagy is Increased Following OGD/R
In Chapter 5 we evaluated the status of mitophagic flux in response to OGD/R. We
report that mitophagic flux was significantly increased at 4 hours of reoxygenation,
indicated by a significant increase in mCherry puncta. Validation that mCherry puncta
were mitochondria inside lysosomes was accomplished by co-localization of mCherry
puncta with LAMP1 (lysosome marker) immunofluorescence as well as total LAMP1
particle counts, which both displayed significant increases after OGD/R. As discussed
previously, our model is based off cells being measured at discrete time points. Real-time
monitoring of mitophagic flux in a single cell would allow precise resolution of the exact
change in mitophagic flux occurring from baseline conditions and throughout OGD/R. To
account for this, I plated coverslips as biological replicates, so each coverslip for a single
time course contained a population of neurons from the same mouse. Additionally, high
technical replication within each biologic replicate was performed to account for variation
among the population of neurons (12 images per coverslip,  70 cells/coverslip).
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4.2 Mitochondria are Cleared Through the PINK1/Parkin and Rab5 Endosomal
Pathway
There are multiple pathways of mitophagy induction and clearance. Studies have
demonstrated that mitophagy is primarily activated through the PINK1/Parkin pathway in
both heart and brain in response to ischemia/reperfusion [260, 286-288]. Utilizing
colocalization techniques and western blot, we found that PINK1 and Parkin translocate
to the mitochondria during OGD/R. PINK1 accumulation occurred early during OGD and
peaked at 2R, just before clearance of mitochondria. Parkin translocation also occurred
early, but persisted through the course of OGD/R. This data is supported by evidence
provided by Ordureau et al., as discussed in Chapter 5, of a feedforward mechanism for
Parkin translocation and mitochondrial ubiquitination [149]. Mitochondrial ubiquitination
was also observed at 2 hours of reoxygenation, which corresponded to the timepoint
where peak increases in PINK1 and Parkin translocation were detected. These results
confirm that mitophagy is activated through the PINK1/Parkin pathway during OGD and
reoxygenation in primary cortical neurons.
To date, most studies have concluded that mitochondria tagged for degradation
are sequestered and transported to the lysosome by autophagosomes, as measured by
LC3 conversion [260, 286, 287]. Recent literature has suggested a pathway for
mitochondrial clearance through PINK1/Parkin mediated Rab5 endosomal transport
[161]. To determine whether mitochondria were transported to lysosomes through
autophagosomes or endosomes, we probed for the LC3 conversion and Rab5 expression
in mitochondrial fractions. We found that mitochondria were being sequestered by
endosomes for transport to lysosomes in our model of OGD and reoxygenation.
4.3 Punctate Mitochondria are Sequestered for Degradation
Chapter 4 demonstrated significant mitochondrial fragmentation in response to

89
OGD/R, with increases in both punctate and swollen morphologies. Previous studies
visualizing mitochondria inside autophagosomes by confocal microscopy and electron
microscopy techniques demonstrate that these mitochondria are generally small (<1 µm
in diameter, 0.75 µm2) [166, 310-312]. Utilizing my classification system, I wanted to
evaluate the predominant morphology for sequestration of mitochondria tagged for
degradation. This analysis revealed that punctate mitochondria represented the majority
of mCherry puncta objects at 85.9%, followed by unbranched objects (8.5%), swollen
objects (5.58%), and networks (0.02%). These data suggest although there may be some
level of “macro” mitophagy, punctate mitochondria are preferentially sequestered for
degradation. No objects detected were larger than 10 µm2, but the average size for all
mCherry objects were 0.549 µm2, while mCherry objects identified as a punctate
morphology had an average size of 0.382 µm2. It is not clear why swollen mitochondria
were are not sequestered by early endosomes, other than the difference in size.
Permeability of swollen mitochondria may also release factors that prevent ESCRT
identification. It may also be an issue of availability of autophagosomes or endosomes
required to transport mitochondria to lysosomes, and the smaller mitochondrial objects
are sequestered first for unknown reasons.
Lysosomes possess an acidic environment designed to degrade its contents.
Although mitoQC cells are designed to allow identification of mitochondria inside
lysosomes by the quenching of GFP with low pH, it is difficult to assess whether mCherry
puncta are mitochondria with mCherry-only fluorescence, or contents of degraded
mitochondria filling up the lysosome. Despite this, our measurements are comparable
with previous studies and since lysosomes are <1.2 µm in diameter, it is likely punctate
mitochondria are sequestered for degradation [166, 310-313].
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In Chapter 4, our data suggests that punctate mitochondria return to control levels
at 2R, while the swollen phenotype is increased throughout late reperfusion and
mitophagic flux is increased at 4R. These data suggest that during early reperfusion,
punctate mitochondria face one of two fates: 1) transition to a swollen morphology or 2)
sequestration for degradation through mitophagy. These data also suggest that
mitophagy may be a restorative process necessary for cellular health in response to
ischemia/reperfusion and that the rapid transition to a swollen phenotype prevents
sequestration for mitophagy and is consistent with cell death.
5. Drp1 and Mitochondrial Quality Control: Current Knowledge and New
Contributions
Investigation of the relationship between mitochondrial dynamics and mitophagy
has been a large area of focus. Mitophagy proteins such as Parkin have been implicated
to have influence on mitochondrial dynamics through the ubiquitination and subsequent
degradation of fission and fusion proteins including Fis1, Drp1, and the mitofusins [236,
314]. Similarly, the mitochondrial fission protein Drp1, has been associated as a key
component of mitophagic processes through governing the segregation of dysfunction
mitochondria tagged for degradation [196, 198, 199, 236]. Inhibition of Drp1 has been
shown to be neuroprotective against ischemia/reperfusion through preventing
mitochondrial fragmentation associated with cell death [231, 233, 241, 242, 279, 290294]. Although inhibition of fission during ischemia may improve outcomes, it remains
unclear whether the same inhibition prevents the clearance of dysfunctional mitochondria
accumulated during reperfusion.
5.1 Drp1KO Stabilizes Mitochondrial Architecture during OGD/R
Drp1KO was achieved in Drp1fl/fl primary cortical neurons with lentiviral-Cre
delivery, resulting in a 75% knockout of Drp1 7 days post-transduction. Utilizing our
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machine learning classification system, we were able to reliably classify mitochondrial
morphology during OGD and reoxygenation in the absence of Drp1. Drp1KO prevented
mitochondrial morphologic disruption at all timepoints of OGD/R as opposed to the
extensive fragmentation observed in controls. Specifically, Drp1KO prevented both
network and unbranched fragmentation during OGD/R. Controls displayed significant
decreases in the total number of networks and unbranched objects during OGD/R.
Networks also had corresponding decreases in mitochondrial network area displaying
significant group effects when compared to Drp1KO, suggesting Drp1 prevents the
fragmentation of larger mitochondrial networks during OGD/R. Consistent with the results
in Chapter 4, the total area of mitochondria in the unbranched state showed no significant
changes, suggesting that fragmentation occurs to smaller unbranched mitochondria,
while larger unbranched mitochondria remain intact. Despite the inhibition of unbranched
fragmentation with Drp1KO, the total area of mitochondria in the unbranched state is
reduced overall compared with controls. This suggests that Drp1 is essential for
maintaining the size of unbranched mitochondria. Preventing fission of networks into large
unbranched mitochondria results in a shift of smaller unbranched mitochondria without
disrupting the number of mitochondria in this state under normal conditions.
Consistent with mitochondrial fragmentation, controls showed significant increases
in the total number of swollen mitochondria as well as the total area of mitochondria in a
swollen state. Drp1KO blocked the increase in swollen objects as well as prevented
changes in mitochondrial swelling as a proportion of total mitochondrial area. These
results suggest that Drp1KO blocks the transition of mitochondria to a swollen
morphology induced by OGD/R. In contrast, total punctate objects showed no significant
differences in either control or Drp1KO groups. With respect to total area of mitochondria
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in a punctate state, significant increases were observed in control cells throughout
OGD/R. Drp1KO prevented any increases in mitochondrial punctate area and was
significantly decreased at 4R. These results suggest that punctate mitochondria are larger
following OGD/R, without observing increases in punctate objects. In addition, Drp1KO
blocked the increase in punctate area likely by preventing mitochondrial fragmentation. It
is unclear if Drp1KO blocks mitochondrial fragmentation to a punctate morphology, thus
indirectly reducing the pool of fragmented mitochondria that can undergo swelling, or if
Drp1 plays a direct role in inducing mitochondrial swelling. There is some evidence to
suggest Drp1 can play a direct role in mediating mitochondrial outer membrane
permeabilization (MOMP) through the association and recruitment of pro-apoptotic
proteins such as Bax and Bak, which trigger mitochondrial swelling, the release of
cytochrome C, and cell death [241, 315-319]. Considering the role Drp1 may play in
mitochondrial permeabilization and the increases in swollen mitochondria we observe in
our data, increases in punctate area suggest Drp-1 dependent fragmentation results in a
rapid transition to a small swollen phenotype, consistent with induction of cell death.
5.2 Mitophagic Flux is Independent of Drp1
We also evaluated the effect of Drp1KO on mitophagic flux during OGD/R.
Significant increases in mCherry puncta were observed in response to OGD/R in controls.
Drp1 KO had no effect on mitophagic flux, also displaying significant increases in mCherry
puncta following OGD/R. Total Lamp1 puncta was also increased in controls and Drp1
revealed no effect, suggesting that mitophagic flux following OGD/R is independent of
Drp1.
Although fission is necessary for mitophagy to occur [196], roughly 45% of
mitochondrial objects are punctate mitochondria in both control and Drp1KO during
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baseline conditions. Large interconnected networks may be more protected from the
deleterious effects of ischemia/reperfusion by mitigating excessive ROS production from
equilibration of matrix metabolites, intact mtDNA, and even membrane components such
as complex I of the electron transport chain [16, 21-24], leaving punctate mitochondria
vulnerable to ROS production and damage. With a large pool of vulnerable punctate
mitochondria at baseline conditions, it is not surprising that mitophagic flux is still
increased despite inhibited fission, especially if punctate mitochondria are the majority of
mitochondria being transported to the lysosome. This likely corresponds to the decrease
in punctate area observed at 4 hours of reoxygenation with Drp1KO. Additionally, recent
evidence suggests that the mitochondrial Rho-GTPases, Miro1 and Miro2, also play a
role in mediating fission in both mitochondria and peroxisomes [320, 321], which may
provide another avenue for dysfunctional mitochondria to be sequestered for degradation.
5.3 Drp1-Independent Mitophagy is not Cleared Through the Rab5 Endosomal
Pathway
We demonstrated that mitophagy was being activated by the PINK1/Parkin
pathway and that mitochondria were being sequestered by Rab5 endosomes for transport
to the lysosome. No changes were observed in PINK1 and Parkin translocation as well
as general ubiquitination of mitochondrial proteins. Interestingly, mitochondrial Rab5
expression was significantly increased in controls and this increase was prevented by
Drp1 KO, suggesting that mitochondria undergoing mitophagy in the absence of Drp1 are
not being sequestered by the endosome for transport to the lysosome.
Lastly, Drp1KO was shown to be neuroprotective in primary cortical neurons
following OGD and reoxygenation, indicated by a 20% improvement in viability. The
improvement in viability is likely caused by an inhibition of mitochondrial fragmentation
that leads to mitochondrial swelling and subsequent activation of cell death pathways.
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Fig. 7-1. Model of physiological fission vs. pathological fission. During normal physiological conditions,
mitochondria exist in an equilibrium of long interconnected networks and small punctate mitochondria
through repeated cycles of fission and fusion. Dysfunctional mitochondria are sequestered and transported
to the lysosome for degradation in a process called mitophagy. Under stress conditions such as
ischemia/reperfusion injury, Drp1 mediates excessive mitochondria fragmentation, which result in rapid
mitochondrial swelling, mitochondrial permeability, and ultimately cell death.

6. Technical Limitations and Merits
A primary limitation to this study is lack of an in vivo model to validate our in vitro
findings. To our credit, we did utilize primary cortical neurons isolated from mice, which
are more physiologically relevant than the use of cell lines. Additionally, this study
provides a solid scientific foundation for the next phase of this project, evaluating this
mechanism in mouse models of brain ischemia/reperfusion. A second limitation as
discussed previously is our lack of temporal resolution through real-time imaging.
Monitoring neurons in real-time as they respond to OGD/R would provide valuable
information in the transition of mitochondrial networks to punctate and swollen
mitochondria in regard to mitochondrial fragmentation. A major limitation of live imaging
is the limited sampling capabilities in real-time. While our study had less temporal
resolution than real-time imaging, we have larger sampling capabilities, thus improving
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confidence in our findings at the discrete timepoints we evaluated.

Additionally,

understanding the events that led to mitochondrial clearance would provide valuable
insight in the progression of mitochondrial turnover in pathological conditions. While
gaining temporal resolution, real-time imaging sacrifices statistical power, which utilizing
our methods demonstrated superiority. Our high-throughput machine learning
classification system was able to measure and classify hundreds of thousands of objects
for a single experiment. Follow-up studies are ongoing to corroborate our findings with
intact biological systems.
7. Conclusions and Future Directions
In consideration of our results, we theorize that mitochondrial dynamics and quality
control are disrupted during ischemia/reperfusion and this contributes to cell death.
Utilizing a highly sensitive and specific machine learning based classification system we
have developed, our data have demonstrated that Drp1 induces extensive mitochondrial
fragmentation in response to OGD/R, which is accompanied by an increase in swollen
mitochondria. Knockout of Drp1 prevented mitochondrial fragmentation and swelling and
is associated with improvements in cell viability. We further demonstrated that mitophagic
flux is increased following OGD/R likely as a restorative process for turnover of damaged
mitochondria. We propose that mitophagy is activated by the PINK1/Parkin pathway and
that mitochondria are sequestered by Rab5 endosomes for transport to lysosomes. We
demonstrated that knockout of Drp1 had no effect on mitophagic flux during OGD/R
suggesting that mitophagy can proceed independent of Drp1-mediated mitochondrial
fragmentation.
This study suggests a possible mechanism of cell death where Drp1 activity and
excessive fragmentation shift the balance from physiological fission and healthy
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mitochondria to pathological mitochondrial swelling, and cell death (Fig. 7-1). Future
studies must further interrogate how enhancement or inhibition of mitophagy may
contribute to mitochondrial quality control during ischemia/reperfusion injury in both in
vitro and in vivo models.
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ABSTRACT
THE DYNAMICS OF LIFE AND DEATH: MITOCHONDRIAL FRAGMENTATION,
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Ischemic brain injury caused by cardiac arrest or stroke continue to be leading
caused of death and disability in the U.S. While restoration of blood flow is necessary to
salvage ischemic tissue, reperfusion paradoxically exacerbates injury via the production
of reactive oxygen species, which, damage mitochondria and induce cell death.
Therefore, it is critical to have stringent quality control mechanisms to ensure a healthy
mitochondrial network. Mitochondrial fragmentation has been well characterized in the
progression of ischemia/reperfusion and its association with cell death. Conversely, the
role of mitophagy has been controversial regarding whether upregulation of mitophagy
serves as a restorative process for the turnover of dysfunctional mitochondria, or have
deleterious effects through energy imbalance and induction of apoptosis. Furthermore,
the interplay between mitochondrial dynamics and mitophagy in ischemia/reperfusion
remains unknown.
Utilizing an in vitro model of ischemia/reperfusion in primary cortical neurons, we
tested four hypotheses:
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i)

Mitochondrial morphology in primary cortical neurons can be classified into 4
distinct groups utilizing a machine-learning based classification sytem.

ii)

Mitochondria

undergo

significant

remodeling

during

oxygen-glucose

deprivation and reoxygenation, resulting in extensive fragmentation and
swelling.
iii)

Mitophagic flux is significantly increased via the PINK1/Parkin pathway of
mitophagy and are sequestered by Rab5 endosomes for transport to the
lysosome. Furthermore, mitochondria inside lysosomes are primarily punctate
mitochondria.

iv)

Knockout of Drp1 stabilizes mitochondrial architecture, but has no effect on
mitophagic flux during OGD/R.
In support of hypothesis I, we demonstrate the development of a highly sensitive

and specific machine-learning based classification system of 4 distinct mitochondrial
morphologies: network, unbranched, swollen, and punctate. Using the Random Forest
algorithm, our high-throughput classification system demonstrated mitochondrial
morphologies can be predicted with accuracy. In agreement with hypothesis II,
mitochondrial fragmentation was quantitatively measured utilizing our machine-learning
classification system during oxygen-glucose deprivation ad reoxygenation. This was
demonstrated by decreases in networks and unbranched mitochondria with
corresponding increases in punctate and swollen mitochondria. In support of hypothesis
III, we demonstrated that mitophagic flux was increased during oxygen-glucose
deprivation, by the presence of mCherry puncta in primary cortical neurons isolated from
mitoQC reporter mice. Additionally, mitophagy was activated by the PINK1/Parkin
pathway of mitophagy and that punctate mitochondria were sequestered by Rab5
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endosomes for transport to the lysosome. Lastly, in support of hypothesis IV, we
demonstrate the KO of Drp1 prevents mitochondrial fragmentation and swelling during
oxygen-glucose deprivation in primary cortical neurons, but has no effect on mitophagic
flux. In conclusion, our results illustrate that in the context of ischemia/reperfusion injury,
Drp1 shifts the balance from physiological fission and healthy mitochondrial turnover, to
pathological fragmentation and swelling inducing cell death.
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